Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models
Rationale Spontaneous (novel) object recognition (SOR) is one of the most widely used rodent behavioural tests. The opportunity for rapid data collection has made SOR a popular choice in studies that explore cognitive impairment in rodent models of schizophrenia, and that test the efficacy of drugs...
Saved in:
Published in | Psychopharmacologia Vol. 220; no. 4; pp. 647 - 672 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer-Verlag
01.04.2012
Springer Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Rationale
Spontaneous (novel) object recognition (SOR) is one of the most widely used rodent behavioural tests. The opportunity for rapid data collection has made SOR a popular choice in studies that explore cognitive impairment in rodent models of schizophrenia, and that test the efficacy of drugs intended to reverse these deficits.
Objectives
We provide an overview of the many recent studies that have used SOR to explore the mnemonic effects of manipulation of the key transmitter systems relevant to schizophrenia—the dopamine, glutamate, GABA, acetylcholine, serotonin and cannabinoid systems—alone or in combination. We also review the use of SOR in studying memory in genetically modified mouse models of schizophrenia, as well as in neurodevelopmental and lesion models. We end by discussing the construct and predictive validity, and translational relevance, of SOR with respect to cognitive impairment in schizophrenia.
Results
Perturbation of the dopamine or glutamate systems can generate robust and reliable impairment in SOR. Impaired performance is also seen following antagonism of the muscarinic acetylcholine system, or exposure to cannabinoid agonists. Cognitive enhancement has been reported using alpha7-nicotinic acetylcholine receptor agonists and 5-HT
6
antagonists. Among non-pharmacological models, neonatal ventral hippocampal lesions and maternal immune activation can impair SOR, while mixed results have been obtained with mice carrying mutations in schizophrenia risk-associated genes, including neuregulin and COMT.
Conclusions
While SOR is not without its limitations, the task represents a useful method for studying manipulations with relevance to cognitive impairment in schizophrenia, as well as the interactions between them. |
---|---|
AbstractList | Rationale Spontaneous (novel) object recognition (SOR) is one of the most widely used rodent behavioral tests. The opportunity for rapid data collection has made SOR a popular choice in studies that explore cognitive impairment in rodent models of schizophrenia, and that test the efficacy of drugs intended to reverse these deficits. Objectives We provide an overview of the many recent studies that have used SOR to explore the mnemonic effects of manipulation of the key transmitter systems relevant to schizophrenia--the dopamine, glutamate, GABA, acetylcholine, serotonin and cannabinoid systems--alone or in combination. We also review the use of SOR in studying memory in genetically modified mouse models of schizophrenia, as well as in neurodevelopmental and lesion models. We end by discussing the construct and predictive validity, and translational relevance, of SOR with respect to cognitive impairment in schizophrenia. Results Perturbation of the dopamine or glutamate systems can generate robust and reliable impairment in SOR. Impaired performance is also seen following antagonism of the muscarinic acetylcholine system, or exposure to cannabinoid agonists. Cognitive enhancement has been reported using alpha7-nicotinic acetylcholine receptor agonists and 5-[HT.sub.6] antagonists. Among non-pharmacological models, neonatal ventral hippocampal lesions and maternal immune activation can impair SOR, while mixed results have been obtained with mice carrying mutations in schizophrenia risk-associated genes, including neuregulin and COMT. Conclusions While SOR is not without its limitations, the task represents a useful method for studying manipulations with relevance to cognitive impairment in schizophrenia, as well as the interactions between them. Keywords Spontaneous object recognition * Novel * Schizophrenia * Memory * Dopamine * Glutamate * Neuregulin * COMT Spontaneous (novel) object recognition (SOR) is one of the most widely used rodent behavioral tests. The opportunity for rapid data collection has made SOR a popular choice in studies that explore cognitive impairment in rodent models of schizophrenia, and that test the efficacy of drugs intended to reverse these deficits. We provide an overview of the many recent studies that have used SOR to explore the mnemonic effects of manipulation of the key transmitter systems relevant to schizophrenia--the dopamine, glutamate, GABA, acetylcholine, serotonin and cannabinoid systems--alone or in combination. We also review the use of SOR in studying memory in genetically modified mouse models of schizophrenia, as well as in neurodevelopmental and lesion models. We end by discussing the construct and predictive validity, and translational relevance, of SOR with respect to cognitive impairment in schizophrenia. Perturbation of the dopamine or glutamate systems can generate robust and reliable impairment in SOR. Impaired performance is also seen following antagonism of the muscarinic acetylcholine system, or exposure to cannabinoid agonists. Cognitive enhancement has been reported using alpha7-nicotinic acetylcholine receptor agonists and 5-HT^sub 6^ antagonists. Among non-pharmacological models, neonatal ventral hippocampal lesions and maternal immune activation can impair SOR, while mixed results have been obtained with mice carrying mutations in schizophrenia risk-associated genes, including neuregulin and COMT. While SOR is not without its limitations, the task represents a useful method for studying manipulations with relevance to cognitive impairment in schizophrenia, as well as the interactions between them.[PUBLICATION ABSTRACT] Rationale Spontaneous (novel) object recognition (SOR) is one of the most widely used rodent behavioural tests. The opportunity for rapid data collection has made SOR a popular choice in studies that explore cognitive impairment in rodent models of schizophrenia, and that test the efficacy of drugs intended to reverse these deficits. Objectives We provide an overview of the many recent studies that have used SOR to explore the mnemonic effects of manipulation of the key transmitter systems relevant to schizophrenia—the dopamine, glutamate, GABA, acetylcholine, serotonin and cannabinoid systems—alone or in combination. We also review the use of SOR in studying memory in genetically modified mouse models of schizophrenia, as well as in neurodevelopmental and lesion models. We end by discussing the construct and predictive validity, and translational relevance, of SOR with respect to cognitive impairment in schizophrenia. Results Perturbation of the dopamine or glutamate systems can generate robust and reliable impairment in SOR. Impaired performance is also seen following antagonism of the muscarinic acetylcholine system, or exposure to cannabinoid agonists. Cognitive enhancement has been reported using alpha7-nicotinic acetylcholine receptor agonists and 5-HT 6 antagonists. Among non-pharmacological models, neonatal ventral hippocampal lesions and maternal immune activation can impair SOR, while mixed results have been obtained with mice carrying mutations in schizophrenia risk-associated genes, including neuregulin and COMT. Conclusions While SOR is not without its limitations, the task represents a useful method for studying manipulations with relevance to cognitive impairment in schizophrenia, as well as the interactions between them. Spontaneous (novel) object recognition (SOR) is one of the most widely used rodent behavioural tests. The opportunity for rapid data collection has made SOR a popular choice in studies that explore cognitive impairment in rodent models of schizophrenia, and that test the efficacy of drugs intended to reverse these deficits. We provide an overview of the many recent studies that have used SOR to explore the mnemonic effects of manipulation of the key transmitter systems relevant to schizophrenia-the dopamine, glutamate, GABA, acetylcholine, serotonin and cannabinoid systems-alone or in combination. We also review the use of SOR in studying memory in genetically modified mouse models of schizophrenia, as well as in neurodevelopmental and lesion models. We end by discussing the construct and predictive validity, and translational relevance, of SOR with respect to cognitive impairment in schizophrenia. Perturbation of the dopamine or glutamate systems can generate robust and reliable impairment in SOR. Impaired performance is also seen following antagonism of the muscarinic acetylcholine system, or exposure to cannabinoid agonists. Cognitive enhancement has been reported using alpha7-nicotinic acetylcholine receptor agonists and 5-HT(6) antagonists. Among non-pharmacological models, neonatal ventral hippocampal lesions and maternal immune activation can impair SOR, while mixed results have been obtained with mice carrying mutations in schizophrenia risk-associated genes, including neuregulin and COMT. While SOR is not without its limitations, the task represents a useful method for studying manipulations with relevance to cognitive impairment in schizophrenia, as well as the interactions between them. Rationale: Spontaneous (novel) object recognition (SOR) is one of the most widely used rodent behavioural tests. The opportunity for rapid data collection has made SOR a popular choice in studies that explore cognitive impairment in rodent models of schizophrenia, and that test the efficacy of drugs intended to reverse these deficits. Objectives: We provide an overview of the many recent studies that have used SOR to explore the mnemonic effects of manipulation of the key transmitter systems relevant to schizophrenia-the dopamine, glutamate, GABA, acetylcholine, serotonin and cannabinoid systems-alone or in combination. We also review the use of SOR in studying memory in genetically modified mouse models of schizophrenia, as well as in neurodevelopmental and lesion models. We end by discussing the construct and predictive validity, and translational relevance, of SOR with respect to cognitive impairment in schizophrenia. Results: Perturbation of the dopamine or glutamate systems can generate robust and reliable impairment in SOR. Impaired performance is also seen following antagonism of the muscarinic acetylcholine system, or exposure to cannabinoid agonists. Cognitive enhancement has been reported using alpha7-nicotinic acetylcholine receptor agonists and 5-HT sub(6) antagonists. Among non-pharmacological models, neonatal ventral hippocampal lesions and maternal immune activation can impair SOR, while mixed results have been obtained with mice carrying mutations in schizophrenia risk-associated genes, including neuregulin and COMT. Conclusions: While SOR is not without its limitations, the task represents a useful method for studying manipulations with relevance to cognitive impairment in schizophrenia, as well as the interactions between them. |
Audience | Academic |
Author | Lyon, L. Bussey, T. J. Saksida, L. M. |
Author_xml | – sequence: 1 givenname: L. surname: Lyon fullname: Lyon, L. organization: Department of Experimental Psychology, University of Cambridge, The MRC and Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge – sequence: 2 givenname: L. M. surname: Saksida fullname: Saksida, L. M. organization: Department of Experimental Psychology, University of Cambridge, The MRC and Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge – sequence: 3 givenname: T. J. surname: Bussey fullname: Bussey, T. J. email: tjb1000@cam.ac.uk organization: Department of Experimental Psychology, University of Cambridge, The MRC and Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25703254$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22068459$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ks1u1DAQxyNURLeFB-CCLBASh6bYTpw4vVUVX1IlDsA5cpxx1ivHDnZ2EbwL78pE2VKBwD7YGv9m_J-Ps-zEBw9Z9pTRS0Zp_TpRylmRU8ZyLooqFw-yDSsLnnNa85NsQ2lR5AUT8jQ7S2lHcZWyfJSdck4rWYpmk_38NAU_Kw9hn0jodqBnEkGHwdvZBk-U74mdE9ocHJTXQOZAkt7aH2HaRvBWXRGFrwcL30gwxFjfWz8kYmIYybRVcVQ6uDBYrdwFGcDDbPUFcZDuwvdwABemEVCHIzH0eCEjHi49zh4a5RI8OZ7n2Ze3bz7fvM9vP777cHN9m2vRNHPOuqarG2Z0U_cck-5kxzpacuh0p6TBbKmSkmtooDCgGTdK6k5XBiGhOC_Os1dr3CmGr3tIczvapMG5tTAtVltivYQsEX3-F7oL--hRXduUXHBZVwKhFys0KAet9SbMUeklZntdiFLUdSUX6vIfFO4eRqux1cai_Q8HtjroGFKKYNop2lHF7yhw0Vi360S0OBHtMhHt4vPsqHffjdD_9rgbAQReHgGVsEcmYpdtuudETQsulsT5yiV88gPE-8T___svqaPRYw |
CODEN | PSYPAG |
CitedBy_id | crossref_primary_10_1016_j_nlm_2019_107041 crossref_primary_10_3390_ijms23115968 crossref_primary_10_1016_j_bbi_2016_07_144 crossref_primary_10_1016_j_euroneuro_2016_07_004 crossref_primary_10_1016_j_biopha_2018_07_030 crossref_primary_10_1097_WNR_0000000000000338 crossref_primary_10_1101_lm_044784_116 crossref_primary_10_1016_j_neuropharm_2016_10_002 crossref_primary_10_1016_j_bbr_2014_09_039 crossref_primary_10_3389_fphar_2024_1357575 crossref_primary_10_1111_jne_13228 crossref_primary_10_1016_j_euroneuro_2015_12_020 crossref_primary_10_1016_j_bbr_2019_02_003 crossref_primary_10_1016_j_ejphar_2017_12_047 crossref_primary_10_3389_fcell_2021_693919 crossref_primary_10_1093_ijnp_pyw062 crossref_primary_10_1016_j_neubiorev_2022_104560 crossref_primary_10_1093_ntr_nty166 crossref_primary_10_1097_FBP_0000000000000200 crossref_primary_10_1007_s00213_013_3011_2 crossref_primary_10_1021_acschemneuro_6b00090 crossref_primary_10_1038_tp_2015_181 crossref_primary_10_1007_s10519_017_9835_5 crossref_primary_10_1007_s12640_018_9888_0 crossref_primary_10_1016_j_neuropharm_2022_109239 crossref_primary_10_1097_FBP_0000000000000483 crossref_primary_10_1016_j_pharep_2018_01_009 crossref_primary_10_1111_bph_13277 crossref_primary_10_1016_j_euroneuro_2023_09_005 crossref_primary_10_1016_j_nlm_2015_02_005 crossref_primary_10_1016_j_euroneuro_2015_04_018 crossref_primary_10_1016_j_neulet_2013_12_016 crossref_primary_10_1016_j_bbr_2014_09_040 crossref_primary_10_1007_s00213_015_4064_1 crossref_primary_10_1016_j_bbr_2015_02_015 crossref_primary_10_1038_tp_2015_75 crossref_primary_10_1016_j_neuropharm_2014_11_004 crossref_primary_10_1016_j_neuron_2021_05_019 crossref_primary_10_1038_tp_2012_68 crossref_primary_10_1016_j_bbr_2014_10_025 crossref_primary_10_1016_j_nlm_2019_03_006 crossref_primary_10_1016_j_bbi_2017_10_024 crossref_primary_10_1038_s41380_021_01038_9 crossref_primary_10_1016_j_neuropsychologia_2012_07_034 crossref_primary_10_1016_j_neubiorev_2013_06_005 crossref_primary_10_1016_j_bbr_2012_11_022 crossref_primary_10_1038_npp_2012_84 crossref_primary_10_1016_j_pnpbp_2014_03_010 crossref_primary_10_1523_ENEURO_0319_21_2021 crossref_primary_10_1007_s00221_021_06099_4 crossref_primary_10_1080_15376516_2022_2053254 crossref_primary_10_1007_s11064_017_2181_4 crossref_primary_10_1097_FBP_0000000000000208 crossref_primary_10_1007_s00441_013_1652_4 crossref_primary_10_1111_gbb_12240 crossref_primary_10_1186_s40478_016_0310_y crossref_primary_10_1038_npp_2015_126 crossref_primary_10_1016_j_euroneuro_2017_11_013 crossref_primary_10_1038_s41598_020_67619_w crossref_primary_10_1007_s00213_014_3577_3 crossref_primary_10_1007_s00213_015_4018_7 crossref_primary_10_1016_j_bbr_2013_10_016 crossref_primary_10_1016_j_ejphar_2012_11_027 crossref_primary_10_3390_ijms22168710 crossref_primary_10_1007_s00213_017_4747_x crossref_primary_10_1016_j_bbr_2021_113338 crossref_primary_10_1007_s00213_014_3509_2 crossref_primary_10_1016_j_euroneuro_2015_07_018 crossref_primary_10_1017_S1461145713000928 crossref_primary_10_1007_s11011_014_9550_3 crossref_primary_10_1038_tp_2017_111 crossref_primary_10_1007_s00213_017_4651_4 crossref_primary_10_1097_FBP_0000000000000418 crossref_primary_10_1007_s12035_015_9212_4 crossref_primary_10_1016_j_bbih_2022_100514 crossref_primary_10_1073_pnas_1418895111 crossref_primary_10_1016_j_bcp_2017_11_017 |
Cites_doi | 10.1016/j.biopsych.2004.09.013 10.1124/jpet.107.133082 10.1126/science.1145194 10.1007/s00221-009-2103-z 10.1093/neucas/7.2.105 10.1007/PL00005603 10.1111/j.1460-9568.2006.05003.x 10.1007/s00213-010-2091-5 10.1073/pnas.0308455101 10.1002/hipo.20864 10.1002/hipo.1072 10.1176/appi.ajp.2007.07050724 10.1038/sj.npp.1301499 10.1016/S0166-4328(00)00155-8 10.1093/schbul/sbi059 10.1038/sj.npp.1301189 10.1016/j.neuropsychologia.2004.03.005 10.1124/jpet.108.150094 10.1002/(SICI)1096-8628(19980710)81:4<308::AID-AJMG6>3.0.CO;2-P 10.1007/s002130050667 10.3758/BF03214225 10.1016/j.biopsych.2006.04.005 10.1016/0166-4328(86)90011-2 10.1073/pnas.0931309100 10.1021/jm021085c 10.1523/JNEUROSCI.3763-03.2004 10.1016/j.biopsych.2005.07.031 10.1007/s00213-008-1240-6 10.1016/j.biopsych.2006.04.006 10.1007/s00213-008-1456-5 10.1101/lm.77806 10.1016/j.bcp.2009.05.030 10.1016/j.neulet.2003.11.049 10.1016/j.neubiorev.2007.01.005 10.1007/s00213-009-1618-0 10.1016/j.bmcl.2010.07.097 10.1016/j.bbr.2010.05.034 10.1016/S0006-3223(98)00279-0 10.1038/sj.npp.1301098 10.1002/(SICI)1096-8628(20000403)96:2<196::AID-AJMG15>3.0.CO;2-4 10.1016/j.pharmthera.2005.05.001 10.1111/j.1460-9568.2005.04055.x 10.1017/S1461145710000659 10.1016/j.schres.2009.08.002 10.1016/S0006-3223(01)01251-3 10.1046/j.0001-690X.2001.acp1c008d.x 10.1038/sj.npp.1301475 10.1186/1471-2350-10-147 10.1016/S0960-894X(00)00670-3 10.1016/j.bbr.2007.06.012 10.1016/S0893-133X(01)00400-6 10.1038/sj.bjp.0703288 10.1523/JNEUROSCI.4111-08.2009 10.1097/01.WNF.0000240940.67241.F6 10.1016/j.bbi.2010.03.004 10.1001/archpsyc.60.12.1187 10.1007/s00213-010-1896-6 10.1038/nm1632 10.1124/pr.110.002642 10.1192/bjp.179.5.403 10.1046/j.1468-1331.2002.00421.x 10.1016/S0896-6273(03)00358-1 10.1016/0893-133X(94)00131-I 10.1016/j.schres.2007.12.491 10.1001/archpsyc.59.11.1011 10.1002/dev.420260605 10.1016/j.neuroscience.2006.09.041 10.1074/jbc.M007631200 10.1007/BF02246090 10.1016/j.bbr.2011.05.008 10.1001/archpsyc.1994.03950030035004 10.1016/S0361-9230(97)00007-5 10.1037/0735-7044.101.4.587 10.1016/S0306-4522(01)00171-3 10.1523/JNEUROSCI.1346-04.2004 10.1016/j.pharmthera.2009.02.004 10.1016/j.schres.2004.08.017 10.1093/brain/115.2.367 10.1523/JNEUROSCI.2818-06.2006 10.1007/s00213-008-1183-y 10.1016/j.neuroscience.2008.05.011 10.1016/S0893-133X(02)00372-X 10.1016/S0301-0082(00)00044-7 10.1097/FBP.0b013e32831c3b06 10.1016/j.biopsych.2007.04.034 10.1038/sj.npp.1300225 10.1016/j.bbr.2004.05.016 10.4088/JCP.1006e12 10.1016/j.nlm.2009.10.002 10.1038/sj.npp.1300450 10.1093/schbul/sbp110 10.1016/j.neuropharm.2006.02.005 10.1016/j.neuroscience.2009.07.061 10.1016/j.neuroscience.2008.07.006 10.1016/j.brainres.2009.07.065 10.1016/j.bbr.2009.11.018 10.1093/schbul/sbi044 10.1007/s00213-010-1931-7 10.1126/science.284.5420.1670 10.1016/S0140-6736(87)92620-1 10.1016/j.ejphar.2006.09.049 10.1176/appi.ajp.161.1.116 10.1037/0097-7403.1.4.326 10.1017/S1461145708009371 10.1037/0278-7393.19.2.397 10.1016/S0920-9964(98)00162-5 10.1038/sj.npp.1301510 10.1136/bmj.318.7181.421 10.1523/JNEUROSCI.2319-06.2006 10.1007/s11065-007-9031-0 10.1002/ajmg.1548 10.1176/appi.neuropsych.15.2.215 10.1017/S1461145710001239 10.1523/JNEUROSCI.2077-08.2008 10.1016/j.tics.2006.08.003 10.1007/s00213-007-0698-y 10.1016/j.nlm.2008.04.009 10.1016/j.neuroscience.2007.07.043 10.1016/j.bbr.2009.08.027 10.1038/ng0196-78 10.1016/j.pneurobio.2009.10.018 10.1016/j.neuropharm.2009.07.022 10.1016/S0301-0082(98)00002-1 10.1098/rstb.2002.1097 10.1016/S0893-133X(96)00018-8 10.1097/00001756-200401190-00003 10.1016/0306-4530(94)90004-3 10.1037/0003-066X.40.4.385 10.1007/s00221-007-1186-7 10.1021/jm0602413 10.1101/lm.46102 10.1016/S0006-3223(00)00245-6 10.1016/j.ejphar.2003.08.101 10.1080/15622970701432551 10.1007/s002130050349 10.1016/j.ejphar.2007.06.018 10.1016/j.bbr.2009.09.048 10.1124/jpet.108.147884 10.1007/s00213-003-1552-5 10.1037/0735-7044.121.5.815 10.1007/s00702-003-0812-1 10.1111/j.1460-9568.2006.05170.x 10.1017/S1461145710000775 10.1016/S0006-8993(02)03570-9 10.1038/sj.npp.1301188 10.1002/syn.20397 10.1002/1096-8628(20010108)105:1<20::AID-AJMG1047>3.0.CO;2-C 10.1016/j.schres.2009.02.001 10.1002/hipo.20059 10.1038/1137 10.1076/jcen.25.7.949.16482 10.1016/j.schres.2007.07.018 10.1016/j.neuroscience.2007.07.019 10.1124/jpet.110.171892 10.1016/j.bbr.2007.07.033 10.1006/nlme.1996.3755 10.1016/j.neuropharm.2009.10.003 10.1016/S0304-3940(98)00358-9 10.1124/jpet.107.126706 10.1001/archpsyc.64.6.633 10.1016/S0006-8993(03)03091-9 10.1016/S0166-4328(00)00259-X 10.1136/bmj.325.7374.1212 10.1192/bjp.bp.106.024448 10.1037/h0037649 10.1176/appi.ajp.162.10.1963 10.1046/j.0953-816x.2001.01631.x 10.1016/S0166-4328(97)86039-1 10.1016/S0920-9964(01)00387-5 10.1016/0006-3223(92)90036-Y 10.1016/S0166-4328(98)00032-1 10.1016/S0006-3223(01)01342-7 10.1523/JNEUROSCI.2999-05.2005 10.1016/0006-3223(94)00252-X 10.1016/j.neuroscience.2007.03.018 10.1016/j.bbr.2008.08.022 10.1016/S0893-133X(02)00282-8 10.1016/j.neubiorev.2008.04.004 10.1007/s00213-010-1854-3 10.1017/S1461145703004024 10.1016/j.biopsych.2005.06.006 10.1017/S1461145710000222 10.1007/s00213-003-1764-8 10.1186/1744-859X-9-27 10.1016/0166-4328(88)90157-X 10.1097/00001756-199908020-00016 10.1007/s00213-005-2235-1 10.1038/nrn1648 10.1038/sj.mp.4001558 10.1038/npp.2008.200 10.1016/j.pbb.2009.06.013 10.1016/S0140-6736(07)61162-3 10.1124/jpet.106.118976 10.1007/s00213-004-2032-2 10.1038/sj.npp.1300777 10.1016/j.brainres.2009.05.004 10.1212/01.wnl.0000266670.35219.0c 10.1016/j.euroneuro.2006.06.009 10.1038/sj.npp.1300881 10.1073/pnas.220398097 10.1001/archpsyc.63.6.630 10.1016/j.euroneuro.2010.06.003 10.1016/j.bmcl.2009.03.077 10.1007/s00213-010-2039-9 10.1038/npp.2010.100 10.1126/science.281.5381.1349 10.1007/s00213-007-0820-1 10.1038/nn1846 10.1136/jnnp.20.1.11 10.1124/jpet.108.136580 10.1016/j.pnpbp.2008.08.001 10.1007/s00213-008-1103-1 10.1176/appi.ajp.161.7.1219 10.1016/j.schres.2005.02.010 10.1016/0166-4328(94)00157-B 10.1016/j.phrs.2010.05.004 10.1017/S1461145709990939 10.1523/JNEUROSCI.0736-10.2010 10.1007/s00213-008-1334-1 10.1111/j.1749-6632.1995.tb17481.x 10.1038/npp.2010.212 10.1002/syn.10210 10.1176/appi.ajp.2008.07071135 10.1016/j.ejphar.2005.07.002 10.1126/science.3854 10.1038/365441a0 10.1007/s10571-006-9062-8 10.1097/01.wnr.0000192738.31029.0a 10.1007/BF02246186 10.1016/S0006-8993(97)81700-3 10.1016/S0891-0618(01)00117-X 10.1016/j.neuroscience.2010.07.042 10.1016/0166-4328(96)00006-X 10.1101/lm.33701 10.1001/archpsyc.61.8.774 10.1038/npp.2008.20 10.1016/j.euroneuro.2007.07.008 10.1016/j.bcp.2009.07.005 10.1016/j.euroneuro.2007.02.011 10.1111/j.1600-0773.1963.tb01730.x 10.1101/lm.92505 10.1016/S0893-133X(01)00265-2 10.1097/FBP.0b013e3282d9e9f9 10.1177/0269881110387840 10.1523/JNEUROSCI.5171-06.2007 10.1093/schbul/sbj052 10.1016/j.pbb.2006.08.007 10.1093/schbul/sbp089 10.1016/S0014-2999(97)81951-6 10.1016/j.bbr.2003.12.004 10.1016/j.bbr.2009.07.014 10.1016/S0006-3223(00)00919-7 10.1016/j.ejphar.2008.08.009 10.1097/YIC.0b013e3280117feb 10.1007/s11064-008-9796-4 10.1021/jm901674f 10.1016/j.pnpbp.2009.09.001 10.1016/j.conb.2005.10.014 10.1523/JNEUROSCI.0480-05.2005 10.1016/j.brainres.2008.04.010 10.1038/sj.mp.4001924 10.1176/ajp.148.11.1474 10.3758/BF03327250 10.1176/ajp.154.7.1013 10.1523/JNEUROSCI.15-11-07150.1995 10.1523/JNEUROSCI.19-01-00495.1999 10.1111/j.1601-183X.2010.00656.x 10.1016/j.nbd.2009.04.003 10.1016/j.bbr.2008.10.011 10.1111/j.1476-5381.1995.tb15020.x 10.1177/070674370705201103 10.1016/j.neuropharm.2004.03.012 10.1176/ajp.156.10.1646 10.1017/S0033291706008221 10.1523/JNEUROSCI.20-23-08853.2000 10.1523/JNEUROSCI.18-18-07075.1998 10.1038/npp.1993.44 10.1111/j.1460-9568.2006.05259.x 10.1111/j.1601-183X.2010.00590.x 10.1016/S0002-9297(07)62950-4 10.1523/JNEUROSCI.16-06-02034.1996 10.1176/jnp.6.4.348 10.1176/ajp.148.2.224 10.1016/j.neuropharm.2011.04.011 10.1073/pnas.0908840106 |
ContentType | Journal Article |
Copyright | Springer-Verlag 2011 2015 INIST-CNRS COPYRIGHT 2012 Springer Springer-Verlag 2012 |
Copyright_xml | – notice: Springer-Verlag 2011 – notice: 2015 INIST-CNRS – notice: COPYRIGHT 2012 Springer – notice: Springer-Verlag 2012 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 88G 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ K9. KB0 M0S M1P M2M NAPCQ P64 PQEST PQQKQ PQUKI PRINS PSYQQ Q9U |
DOI | 10.1007/s00213-011-2536-5 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Animal Behavior Abstracts Chemoreception Abstracts Nursing & Allied Health Database (ProQuest) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Psychology Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Chemoreception Abstracts ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Animal Behavior Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | ProQuest One Psychology MEDLINE Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1432-2072 |
EndPage | 672 |
ExternalDocumentID | 2619113651 A354577685 10_1007_s00213_011_2536_5 22068459 25703254 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GroupedDBID | -4W -BR .55 3SX 40D 40E 95. 95~ ABMNI AGWIL ALMA_UNASSIGNED_HOLDINGS KOW N2Q R9- RHV SBY SOJ X7M ~EX IQODW --- -56 -5G -EM -Y2 -~C .86 .GJ .VR 04C 06C 06D 0R~ 0VY 123 199 1N0 1SB 2.D 203 28- 29P 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2QV 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 53G 5QI 5RE 5VS 67N 67Z 6NX 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 96X AAAVM AABHQ AACDK AAEOY AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAQLM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDBF ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABIVO ABJNI ABJOX ABKCH ABKTR ABMQK ABNWP ABPLI ABQBU ABSXP ABTAH ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIPQ ACIWK ACKNC ACMDZ ACMLO ACNCT ACOKC ACOMO ACPRK ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFFNX AFGCZ AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. B0M BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BMSDO BPHCQ BVXVI CAG CCPQU CGR COF CS3 CSCUP CUY CVF DDRTE DL5 DNIVK DPUIP DU5 DWQXO DXH EAD EAP EBC EBD EBLON EBS ECM EIF EIHBH EIOEI EJD EMB EMK EMOBN EN4 EPAXT EPL EPS ESBYG ESX EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO ICJ IHE IHR IJ- IKXTQ IMOTQ INH INR IPY ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M1P M2M M4Y MA- MK0 N9A NAPCQ NB0 NDZJH NPM NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P PF- PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TN5 TSG TSK TSV TUC TUS U2A U9L UAP UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WIP WJK WK6 WK8 WOW XOL YLTOR YQJ YYP Z45 Z7U Z7W Z82 Z83 Z87 Z8O Z8Q Z8V Z8W Z91 ZGI ZMTXR ZOVNA ZY4 ~8M AAYXX CITATION 7QG 7QR 7TK 7XB 8FD 8FK FR3 K9. P64 PQEST PQUKI PRINS Q9U |
ID | FETCH-LOGICAL-c599t-1b9b791fc97d2003b8b1b042ebcba8f2200a882ce9e3fec12fa8cbc6fb045a223 |
IEDL.DBID | AGYKE |
ISSN | 0033-3158 |
IngestDate | Thu Apr 11 21:28:30 EDT 2024 Thu Oct 10 16:42:10 EDT 2024 Tue Nov 19 21:06:55 EST 2024 Tue Nov 12 23:34:39 EST 2024 Fri Dec 06 03:04:29 EST 2024 Tue Oct 15 23:44:06 EDT 2024 Tue Sep 20 22:52:24 EDT 2022 Wed Jul 19 03:58:57 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Novel Dopamine Memory Schizophrenia Neuregulin Spontaneous object recognition Glutamate COMT Animal model Enzyme Transferases Catechol O-methyltransferase Review Catecholamine Psychosis Methyltransferases Animal Excitatory aminoacid Neurotransmitter Development Genetics Lesion Recognition |
Language | English |
License | CC BY 4.0 http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c599t-1b9b791fc97d2003b8b1b042ebcba8f2200a882ce9e3fec12fa8cbc6fb045a223 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 22068459 |
PQID | 942528765 |
PQPubID | 47309 |
PageCount | 26 |
ParticipantIDs | proquest_miscellaneous_1008845584 proquest_journals_942528765 gale_infotracmisc_A354577685 gale_infotracacademiconefile_A354577685 crossref_primary_10_1007_s00213_011_2536_5 pubmed_primary_22068459 pascalfrancis_primary_25703254 springer_journals_10_1007_s00213_011_2536_5 |
PublicationCentury | 2000 |
PublicationDate | 2012-04-01 |
PublicationDateYYYYMMDD | 2012-04-01 |
PublicationDate_xml | – month: 04 year: 2012 text: 2012-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Berlin – name: Germany – name: Heidelberg |
PublicationTitle | Psychopharmacologia |
PublicationTitleAbbrev | Psychopharmacology |
PublicationTitleAlternate | Psychopharmacology (Berl) |
PublicationYear | 2012 |
Publisher | Springer-Verlag Springer Springer Nature B.V |
Publisher_xml | – name: Springer-Verlag – name: Springer – name: Springer Nature B.V |
References | Freedman, Leonard, Gault, Hopkins, Cloninger, Kaufmann, Tsuang, Farone, Malaspina, Svrakic, Sanders, Gejman (CR92) 2001; 105 Dere, Huston, De Souza Silva (CR71) 2007; 31 Winters, Bussey (CR276) 2005; 25 Warburton, Koder, Cho, Massey, Duguid, Barker, Aggleton, Bashir, Brown (CR273) 2003; 38 Adler, Malhotra, Elman, Goldberg, Egan, Pickar, Breier (CR2) 1999; 156 CR284 Mitchell, Neumaier (CR188) 2005; 108 Mumby, Pinel, Wood (CR192) 1990; 18 Papaleo, Crawley, Song, Lipska, Pickel, Weinberger, Chen (CR206) 2008; 28 Shirayama, Yamamoto, Nishimura, Katayama, Kawahara (CR246) 2007; 17 Lee, Lee, Lee, Kim (CR151) 2007; 22 Pietá Dias, Martins de Lima, Presti-Torres, Dornelles, Garcia, Siciliani Scalco, Rewsaat Guimarães, Constantino, Budni, Dal-Pizzol, Schröder (CR212) 2007; 146 Grayson, Idris, Neill (CR101) 2007; 184 Smith, Uslaner, Yao, Mullins, Surles, Huszar, McNaughton, Pascarella, Kandebo, Hinchliffe, Sparey, Brandon, Jones, Venkatraman, Young, Sachs, Jacobson, Hutson (CR253) 2009; 328 Hersi, Richard, Gaudreau, Quirion (CR117) 1995; 15 Pelletier, Achim, Montoya, Lal, Lepage (CR209) 2005; 74 Biton, Bergis, Galli, Nedelec, Lochead, Jegham, Godet, Lanneau, Santamaria, Chesney, Leonardon, Granger, Debono, Bohme, Sgard, Besnard, Graham, Coste, Oblin, Curet, Vige, Voltz, Rouquier, Souilhac, Santucci, Gueudet, Francon, Steinberg, Griebel, Oury-Donat, George, Avenet, Scatton (CR25) 2007; 32 Brown, Begg, Gravenstein, Schaefer, Wyatt, Bresnahan, Babulas, Susser (CR35) 2004; 61 Rasmusson (CR221) 2000; 115 Lieben, Blokland, Sik, Sung, van Nieuwenhuizen, Schreiber (CR160) 2005; 30 Belcher, Feinstein, O’Dell, Marshall (CR20) 2008; 33 Buchanan, Conley, Dickinson, Ball, Feldman, Gold, McMahon (CR37) 2008; 165 Gardiner (CR98) 1988; 16 Minzenberg, Poole, Benton, Vinogradov (CR185) 2004; 161 Buchanan, Summerfelt, Tek, Gold (CR36) 2003; 59 Steckler, Sahgal (CR256) 1995; 67 Winters, Bussey (CR277) 2005; 21 Clancy, Darlington, Finlay (CR50) 2001; 105 Shiina, Shirayama, Niitsu, Hashimoto, Yoshida, Hasegawa, Haraguchi, Kanahara, Shiraishi, Fujisaki, Fukami, Nakazato, Iyo, Hashimoto (CR245) 2010; 9 Hultman, Sparen, Takei, Murray, Cnattingius (CR125) 1999; 318 Pitsikas, Rigamonti, Cella, Muller (CR213) 2003; 983 Diaz-Mataix, Scorza, Bortolozzi, Toth, Celada, Artigas (CR74) 2005; 25 Tsai, Yang, Chung, Lange, Coyle (CR264) 1998; 44 Ozawa, Hashimoto, Kishimoto, Shimizu, Ishikura, Iyo (CR205) 2006; 59 CR289 Ballaz, Akil, Watson (CR14) 2007; 149 Wallace, Callahan, Tehim, Bertrand, Tombaugh, Wang, Xie, Rowe, Ong, Graham, Terry, Rodefer, Herbert, Murray, Porter, Santarelli, Lowe (CR272) 2011; 336 Devito, Balu, Kanter, Lykken, Basu, Coyle, Eichenbaum (CR72) 2010; 10 King, Spicer, Sleight, Marsden, Fone (CR143) 2009; 202 Puma, Bizot (CR215) 1998; 248 Hashimoto, Fujita, Shimizu, Iyo (CR110) 2005; 519 Hauser, Kucinski, Jordan, Gatto, Wersinger, Hesse, Stachowiak, Stachowiak, Papke, Lippiello, Bencherif (CR112) 2009; 78 Kapur, Remington (CR137) 2001; 50 Carli, Bonalumi, Samanin (CR45) 1997; 774 Seeman, Lee (CR242) 1975; 188 Jones, Higgins (CR133) 1995; 120 Olincy, Harris, Johnson, Pender, Kongs, Allensworth, Ellis, Zerbe, Leonard, Stevens, Stevens, Martin, Adler, Soti, Kem, Freedman (CR200) 2006; 63 Bussey, Muir, Aggleton (CR39) 1999; 19 Pereira, Strapasson, Nabinger, Achaval, Netto (CR210) 2008; 1218 Meyer, Feldon (CR182) 2010; 90 Sams-Dodd, Lipska, Weinberger (CR233) 1997; 132 Sydserff, Sutton, Song, Quirk, Maciag, Li, Jonak, Gurley, Gordon, Christian, Doherty, Hudzik, Johnson, Mrzljak, Piser, Smagin, Wang, Widzowski, Smith (CR260) 2009; 78 Jenkins, Harte, Stenson, Reynolds (CR131) 2009; 205 Dawson, Nguyen, Li (CR66) 2001; 25 Roncarati, Scali, Comery, Grauer, Aschmi, Bothmann, Jow, Kowal, Gianfriddo, Kelley, Zanelli, Ghiron, Haydar, Dunlop, Terstappen (CR230) 2009; 329 Botton, Costa, Ardais, Mioranzza, Souza, da Rocha, Porciuncula (CR28) 2010; 214 Smith, Lindenmayer, Davis, Cornwell, Noth, Gupta, Sershen, Lajtha (CR252) 2009; 110 Sambeth, Riedel, Smits, Blokland (CR232) 2007; 572 Vigano, Guidali, Petrosino, Realini, Rubino, Di Marzo, Parolaro (CR270) 2009; 12 Winters, Saksida, Bussey (CR280) 2008; 32 Byrne, Agerbo, Bennedsen, Eaton, Mortensen (CR42) 2007; 97 Heckers, Rauch, Goff, Savage, Schacter, Fischman, Alpert (CR114) 1998; 1 Lewis, Hashimoto, Volk (CR158) 2005; 6 Lung, Shu, Kao, Chen, Ku, Tzeng (CR166) 2009; 10 Herring, Schaefer, Gudelsky, Vorhees, Williams (CR116) 2008; 199 Seeman, Guan, Van Tol (CR243) 1993; 365 Carlsson, Lindqvist (CR46) 1963; 20 Clark, Zola, Squire (CR51) 2000; 20 Dyer, Freudenreich, Culhane, Pachas, Deckersbach, Murphy, Goff, Evins (CR80) 2008; 102 McKee, Squire (CR177) 1993; 19 Levin, Rezvani (CR153) 2006; 98 McLean, Woolley, Thomas, Neill (CR179) 2009; 206 Tulving (CR266) 1985; 40 Aisa, Tordera, Lasheras, Del Rio, Ramirez (CR6) 2008; 154 Levin, Rose (CR154) 1995; 757 Schroder, O’Dell, Marshall (CR238) 2003; 49 Forwood, Winters, Bussey (CR88) 2005; 15 Levine, Berkenbosch, Suchecki, Tilders (CR157) 1994; 19 Lipska, Aultman, Verma, Weinberger, Moghaddam (CR163) 2002; 27 Karasawa, Hashimoto, Chaki (CR138) 2008; 186 Chan, Chiu, Sou, Chen (CR47) 2008; 198 Hirst, Stean, Rogers, Sunter, Pugh, Moss, Bromidge, Riley, Smith, Bartlett, Heidbreder, Atkins, Lacroix, Dawson, Foley, Regan, Upton (CR119) 2006; 553 Danion, Huron, Vidailhet, Berna (CR62) 2007; 52 Schubert, Young, Hicks (CR239) 2006; 60 Babovic, O’Tuathaigh, O’Connor, O’Sullivan, Tighe, Croke, Karayiorgou, Gogos, Cotter, Waddington (CR12) 2008; 155 Harrison, Weinberger (CR108) 2005; 10 Fagerlund, Soholm, Fink-Jensen, Lublin, Glenthoj (CR87) 2007; 30 Maia, de Mendonca (CR169) 2002; 9 Duffy, Cappas, Lai, Boucher, Karl (CR79) 2010; 170 Ichikawa, Li, Dai, Meltzer (CR127) 2002; 956 Aggleton, Keen, Warburton, Bussey (CR5) 1997; 43 Damgaard, Larsen, Hansen, Grayson, Neill, Plath (CR60) 2010; 207 Lieberman, Papadakis, Csernansky, Litman, Volavka, Jia, Gage (CR161) 2009; 34 Albuquerque, Alkondon, Pereira, Castro, Schrattenholz, Barbosa, Bonfante-Cabarcas, Aracava, Eisenberg, Maelicke (CR8) 1997; 280 Macor, Gurley, Lanthorn, Loch, Mack, Mullen, Tran, Wright, Gordon (CR168) 2001; 11 Niwa, Matsumoto, Mouri, Ozaki, Nabeshima (CR198) 2011; 14 Shirazi-Southall, Rodriguez, Nomikos (CR247) 2002; 26 Marcos, Gil-Bea, Hirst, Garcia-Alloza, Ramirez (CR172) 2006; 24 McLean, Grayson, Idris, Lesage, Pemberton, Mackie, Neill (CR180) 2011; 21 Krystal, Karper, Seibyl, Freeman, Delaney, Bremner, Heninger, Bowers, Charney (CR145) 1994; 51 Zanassi, Paolillo, Feliciello, Avvedimento, Gallo, Schinelli (CR290) 2001; 276 de Leon, Diaz (CR68) 2005; 76 Harris, Kongs, Allensworth, Martin, Tregellas, Sullivan, Zerbe, Freedman (CR107) 2004; 29 Quinn, Matsumoto, Callaghan, Long, Arnold, Gunasekaran, Thompson, Dawson, Mallet, Kashem, Matsuda-Matsumoto, Iwazaki, McGregor (CR216) 2008; 33 Camarasa, Rodrigo, Pubill, Escubedo (CR44) 2010; 62 Krystal, D’Souza, Madonick, Petrakis (CR146) 1999; 35 Stober, Saar, Ruschendorf, Meyer, Nurnberg, Jatzke, Franzek, Reis, Lesch, Wienker, Beckmann (CR257) 2000; 67 Riemer, Borroni, Levet-Trafit, Martin, Poli, Porter, Bos (CR224) 2003; 46 Ebstein, Novick, Umansky, Priel, Osher, Blaine, Bennett, Nemanov, Katz, Belmaker (CR82) 1996; 12 Ennaceur, Neave, Aggleton (CR86) 1997; 113 Schiapparelli, Simon, Del Rio, Frechilla (CR235) 2006; 50 Woo, Miller, Lewis (CR283) 1997; 154 Malaspina, Harkavy-Friedman, Corcoran, Mujica-Parodi, Printz, Gorman, Van Heertum (CR170) 2004; 56 Freedman, Olincy, Buchanan, Harris, Gold, Johnson, Allensworth, Guzman-Bonilla, Clement, Ball, Kutnick, Pender, Martin, Stevens, Wagner, Zerbe, Soti, Kem (CR93) 2008; 165 Messier (CR181) 1997; 67 Akhondzadeh, Gerami, Noroozian, Karamghadiri, Ghoreishi, Abbasi, Rezazadeh (CR7) 2008; 32 Cowell, Bussey, Saksida (CR54) 2006; 26 Javitt (CR130) 2009; 35 Jones, Brown, Auer, Fone (CR134) 2010; 214 Yonelinas, Aly, Wang, Koen (CR287) 2010; 20 Friedman, Adler, Howanitz, Harvey, Brenner, Temporini, White, Parrella, Davis (CR95) 2002; 51 Leonard, Gault, Moore, Hopkins, Robinson, Olincy, Adler, Cloninger, Kaufmann, Tsuang, Faraone, Malaspina, Svrakic, Freedman (CR152) 1998; 81 Davis, Kahn, Ko, Davidson (CR63) 1991; 148 Hannesson, Vacca, Howland, Phillips (CR106) 2004; 153 Harvey, Moriarty, Friedman, White, Parrella, Mohs, Davis (CR109) 2000; 47 Keefe, Bilder, Davis, Harvey, Palmer, Gold, Meltzer, Green, Capuano, Stroup, McEvoy, Swartz, Rosenheck, Perkins, Davis, Hsiao, Lieberman (CR139) 2007; 64 Prast, Philippu (CR214) 2001; 64 Mishkin, Delacour (CR186) 1975; 1 Woolley, Marsden, Sleight, Fone (CR285) 2003; 170 Winters, Bartko, Saksida, Bussey (CR281) 2010; 93 Johnson, Forbes, Watson, Garzya, Stevenson, Walker, Mudhar, Flynn, Wyman, Smith, Murkitt, Lucas, Mookherjee, Watson, Gartlon, Bradford, Brown (CR132) 2010; 20 Levin, Simon (CR155) 1998; 138 CR21 Dawson, Nguyen, Li (CR65) 2000; 130 O’Tuathaigh, O’Sullivan, Kinsella, Harvey, Tighe, Croke, Waddington (CR201) 2006; 17 Clarke, Rossato, Monteiro, Bevilaqua, Izquierdo, Cammarota (CR53) 2008; 90 Massey, Bhabra, Cho, Brown, Bashir (CR174) 2001; 14 Abe, Ishida, Iwasaki (CR1) 2004; 356 Young, Powell, Risbrough, Marston, Geyer (CR288) 2009; 122 Calkins, Gur, Ragland, Gur (CR43) 2005; 162 Myers, Robles, Kakoyannis, Sherr, Avila, Blaxton, Thaker (CR193) 2004; 174 Nilsson, Hansson, Carlsson, Carlsson (CR197) 2007; 149 Seidman, Lanca, Kremen, Faraone, Tsuang (CR244) 2003; 25 Coyle (CR55) 2006; 26 Noda, Mouri, Ando, Waki, Yamada, Yoshimi, Yamada, Ozaki, Wang, Nabeshima (CR199) 2010; 13 Bussey, Duck, Muir, Aggleton (CR40) 2000; 111 Doleviczenyi, Vizi, Gacsalyi, Pallagi, Volk, Harsing, Halmos, Lendvai, Zelles (CR77) 2008; 33 Guo, Zhang, Chen, Cai, Cheng, Yang, Jin, Zhen (CR105) 2009; 115 Ennaceur, Delacour (CR84) 1988; 31 Pichat, Bergis, Terranova, Urani, Duarte, Santucci, Gueudet, Voltz, Steinberg, Stemmelin, Oury-Donat, Avenet, Griebel, Scatton (CR211) 2007; 32 de Lima, Laranja, Bromberg, Roesler, Schröder (CR69) 2005; 156 Bradley, Lameh, Ohrmund, Son, Bajpai, Nguyen, Friberg, Burstein, Spalding, Ott, Schiffer, Tabatabaei, McFarland, Davis, Bonhaus (CR30) 2010; 58 O’Tuathaigh, Hryniewiecka, Behan, Tighe, Coughlan, Desbonnet, Cannon, Karayiorgou, 19379814 - Neurobiol Dis. 2009 Aug;35(2):193-200 19482012 - Biochem Pharmacol. 2009 Oct 1;78(7):803-12 12413639 - Schizophr Res. 2003 Jan 1;59(1):29-33 20412316 - Genes Brain Behav. 2010 Aug;9(6):592-602 20553881 - Pharmacol Res. 2010 Nov;62(5):450-6 8190834 - Psychoneuroendocrinology. 1994;19(2):143-53 16271459 - Curr Opin Neurobiol. 2005 Dec;15(6):730-7 8119484 - Dev Psychobiol. 1993 Sep;26(6):345-57 18554808 - Neuroscience. 2008 Jul 17;154(4):1218-26 18793679 - Behav Brain Res. 2009 Jan 30;197(1):210-8 11483296 - Neuroscience. 2001;105(1):7-17 20219155 - Int J Neuropsychopharmacol. 2010 Nov;13(10):1343-54 9725745 - Psychopharmacology (Berl). 1998 Aug;138(3-4):217-30 17548746 - Arch Gen Psychiatry. 2007 Jun;64(6):633-47 10518181 - Am J Psychiatry. 1999 Oct;156(10):1646-9 11927183 - Neuropsychopharmacology. 2002 May;26(5):583-94 16780811 - Biol Psychiatry. 2006 Sep 15;60(6):645-9 16306396 - J Neurosci. 2005 Nov 23;25(47):10831-43 14060771 - Acta Pharmacol Toxicol (Copenh). 1963;20:140-4 17445991 - Neuroscience. 2007 Jun 8;146(4):1719-25 18789179 - Int J Neuropsychopharmacol. 2009 Jun;12(5):599-614 12818183 - Neuron. 2003 Jun 19;38(6):987-96 13680442 - J Clin Exp Neuropsychol. 2003 Oct;25(7):949-64 8454964 - J Exp Psychol Learn Mem Cogn. 1993 Mar;19(2):397-404 17107235 - J Clin Psychiatry. 2006 Oct;67(10):e12 17122043 - J Neurosci. 2006 Nov 22;26(47):12186-97 18753411 - J Pharmacol Exp Ther. 2008 Dec;327(3):827-39 17112674 - Neuroscience. 2007 Jan 5;144(1):1-7 19158311 - J Neurosci. 2009 Jan 21;29(3):871-81 9674976 - Am J Med Genet. 1998 Jul 10;81(4):308-12 21029376 - Genes Brain Behav. 2011 Mar;10 (2):210-22 10195166 - Nat Neurosci. 1998 Aug;1(4):318-23 7548469 - Biol Psychiatry. 1995 Jul 1;38(1):22-33 3964405 - Behav Brain Res. 1986 Feb;19(2):133-46 18984010 - Behav Brain Res. 2009 Feb 11;197(2):435-41 15289276 - Arch Gen Psychiatry. 2004 Aug;61(8):774-80 19269307 - Pharmacol Ther. 2009 May;122(2):150-202 17293705 - Int Clin Psychopharmacol. 2007 Mar;22(2):63-8 18325740 - Schizophr Res. 2008 Jul;102(1-3):88-95 9721099 - Science. 1998 Aug 28;281(5381):1349-52 14702259 - Am J Psychiatry. 2004 Jan;161(1):116-24 20571781 - Psychopharmacology (Berl). 2010 Aug;211(3):277-89 20631688 - Neuropsychopharmacology. 2010 Oct;35(11):2262-73 17637607 - Neuropsychopharmacology. 2008 May;33(6):1453-63 11212100 - Bioorg Med Chem Lett. 2001 Feb 12;11(3):319-21 17344392 - J Neurosci. 2007 Mar 7;27(10):2548-59 17989968 - Exp Brain Res. 2008 Mar;185(4):595-601 12123544 - Chin Med J (Engl). 2002 Jun;115(6):819-23 17907814 - Behav Neurosci. 2007 Oct;121(5):815-25 17694436 - Neuropsychol Rev. 2007 Sep;17(3):275-97 2892048 - Lancet. 1987 Dec 26;2(8574):1483-6 17415795 - Synapse. 2007 Jul;61(7):515-22 15949648 - Schizophr Res. 2005 Jul 15;76(2-3):135-57 16585793 - Learn Mem. 2006 Mar-Apr;13(2):178-86 9452205 - Brain Res. 1997 Nov 7;774(1-2):167-74 15869523 - Eur J Neurosci. 2005 Apr;21(8):2263-70 19660530 - Neuroscience. 2009 Dec 1;164(2):692-701 8914115 - Neuropsychopharmacology. 1996 Nov;15(5):429-36 20950517 - Int J Neuropsychopharmacol. 2011 May;14(4):459-77 9618747 - Prog Neurobiol. 1998 Jun;55(2):149-89 14623357 - Eur J Pharmacol. 2003 Nov 7;480(1-3):133-50 20553765 - Behav Brain Res. 2010 Dec 25;214(2):254-9 19903874 - Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20039-44 19833806 - Schizophr Bull. 2009 Nov;35(6):1059-64 20040103 - BMC Med Genet. 2009 Dec 29;10:147 11139572 - J Biol Chem. 2001 Apr 13;276(15):11487-95 11027310 - Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12375-9 16821801 - J Med Chem. 2006 Jul 13;49(14 ):4425-36 19005465 - Neuropsychopharmacology. 2009 Apr;34(5):1322-9 10439454 - Neuroreport. 1999 Aug 2;10(11):2307-11 7779290 - Behav Brain Res. 1995 Mar;67(2):165-99 9292631 - Psychopharmacology (Berl). 1997 Aug;132(3):303-10 19857543 - Prog Neurobiol. 2010 Mar;90(3):285-326 19627999 - Neuropharmacology. 2009 Oct-Nov;57(5-6):531-8 13680084 - Psychopharmacology (Berl). 2003 Dec;170(4):358-67 19251401 - Schizophr Res. 2009 May;110(1-3):149-55 16806095 - Biol Psychiatry. 2006 Sep 15;60(6):530-3 16987546 - Pharmacol Biochem Behav. 2006 Sep;85(1):253-60 17019409 - Neuropsychopharmacology. 2007 Jan;32(1):1-16 8848531 - Psychopharmacology (Berl). 1995 Nov;122(2):158-68 16936709 - Neuropsychopharmacology. 2007 Jan;32(1):17-34 12888772 - Neuropsychopharmacology. 2003 Oct;28(10 ):1760-9 15036627 - Neurosci Lett. 2004 Feb 19;356(3):191-4 7841806 - J Neuropsychiatry Clin Neurosci. 1994 Fall;6(4):348-57 14997272 - Psychopharmacology (Berl). 2004 Jul;174(3):334-40 3228475 - Behav Brain Res. 1988 Nov 1;31(1):47-59 12464463 - Neuropsychopharmacology. 2002 Dec;27(6):1056-70 17675172 - Behav Brain Res. 2007 Nov 22;184(1):31-8 17826918 - Neuroscience. 2007 Oct 12;149(1):123-30 15106822 - Neuroreport. 2004 Jan 19;15(1):9-12 15263907 - Mol Psychiatry. 2005 Jan;10(1):40-68; image 5 19835892 - Neuropharmacology. 2010 Feb;58(2):365-73 18499253 - Neurosci Biobehav Rev. 2008 Jul;32(5):1055-70 9870977 - J Neurosci. 1999 Jan 1;19(1):495-502 18674597 - Neuroscience. 2008 Sep 9;155(4):1021-9 18514167 - Brain Res. 2008 Jul 7;1218:257-66 3651236 - Behav Neurosci. 1987 Aug;101(4):587-90 17272964 - Clin Neuropharmacol. 2007 Jan-Feb;30(1):3-12 17764905 - Schizophr Res. 2007 Dec;97(1-3):51-9 15601602 - Biol Psychiatry. 2004 Dec 15;56(12 ):931-7 16989988 - Eur Neuropsychopharmacol. 2007 Mar;17(4):277-88 9456005 - Eur J Pharmacol. 1997 Nov 5;338(2):R3-5 17277774 - Nat Neurosci. 2007 Mar;10(3):376-84 9867236 - Behav Brain Res. 1998 Dec;97(1-2):107-13 19514097 - World J Biol Psychiatry. 2009;10(2):156-62 8528256 - Nat Genet. 1996 Jan;12(1):78-80 20170099 - J Med Chem. 2010 Mar 25;53(6):2521-7 17467960 - Eur Neuropsychopharmacol. 2007 Sep;17(9):616-26 9736631 - J Neurosci. 1998 Sep 15;18(18):7075-83 19020411 - Behav Pharmacol. 2008 Dec;19(8):765-76 17241289 - Eur J Neurosci. 2007 Jan;25(1):281-90 21150906 - Neuropsychopharmacology. 2011 Mar;36(4):782-92 16005519 - Pharmacol Ther. 2005 Dec;108(3):320-33 15229054 - Am J Psychiatry. 2004 Jul;161(7):1219-23 17869441 - Neuroscience. 2007 Oct 12;149(1):192-202 1420646 - Biol Psychiatry. 1992 Aug 15;32(4):312-33 21088042 - J Psychopharmacol. 2011 Jun;25(6):792-800 3173093 - Mem Cognit. 1988 Sep;16(5):446-51 7582540 - Br J Pharmacol. 1995 Aug;115(7):1169-74 11001582 - Am J Hum Genet. 2000 Nov;67(5):1201-7 19615981 - Biochem Pharmacol. 2009 Oct 1;78(7):880-8 17541112 - Br J Psychiatry. 2007 Jun;190:515-20 16935547 - Trends Cogn Sci. 2006 Oct;10(10):455-63 16160711 - Neuropsychopharmacology. 2006 Mar;31(3):637-43 12418934 - Arch Gen Psychiatry. 2002 Nov;59(11):1011-20 19198810 - Psychopharmacology (Berl). 2009 Jun;204(2):251-64 14741060 - Int J Neuropsychopharmacol. 2004 Jun;7(2):117-23 16620883 - Neuropharmacology. 2006 Jun;50(7):897-907 18418367 - Neuropsychopharmacology. 2008 Nov;33(12 ):2934-45 17986678 - Am J Psychiatry. 2008 Jan;165(1):82-9 16199846 - Am J Psychiatry. 2005 Oct;162(10):1963-6 12768354 - J Neural Transm (Vienna). 2003 Jun;110(6):577-90 17265076 - Psychopharmacology (Berl). 2007 Apr;191(3):745-58 18727948 - Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1810-5 19631237 - Behav Brain Res. 2009 Dec 28;205(2):355-9 21530550 - Neuropharmacology. 2012 Mar;62(3):1191-203 11803510 - Am J Med Genet. 2001 Dec 8;105(8):655-7 11488958 - Eur J Neurosci. 2001 Jul;14(1):145-52 11743942 - Biol Psychiatry. 2001 Dec 1;50(11):873-83 9974454 - BMJ. 1999 Feb 13;318(7181):421-6 15558543 - Hippocampus. 2005;15(3):347-55 20959364 - J Pharmacol Exp Ther. 2011 Jan;336(1):242-53 16166607 - Schizophr Bull. 2005 Oct;31(4):954-61 20227486 - Brain Behav Immun. 2010 Aug;24(6):930-41 10190224 - Schizophr Res. 1999 Mar 1;35 Suppl:S35-49 8604048 - J Neurosci. 1996 Mar 15;16(6):2034-43 18839151 - Psychopharmacology (Berl). 2009 Jan;202(1-3):111-23 17146471 - Mol Psychiatry. 2007 Mar;12(3):232-46 11782241 - Acta Psychiatr Scand. 2001 Dec;104(6):469-72 18663573 - Neurochem Res. 2008 Nov;33(11):2364-72 19629447 - Psychopharmacology (Berl). 2009 Oct;206(3):403-14 13406589 - J Neurol Neurosurg Psychiatry. 1957 Feb;20(1):11-21 8413587 - Nature. 1993 Sep 30;365(6445):441-5 19825423 - Neurobiol Learn Mem. 2010 Feb;93(2):221-8 19643092 - Brain Res. 2009 Oct 19;1294:116-27 12062906 - Neuropsychopharmacology. 2002 Jul;27(1):47-54 21620900 - Behav Brain Res. 2011 Oct 31;224(2):223-32 20573264 - Ann Gen Psychiatry. 2010 Jun 24;9:27 11250062 - Prog Neurobiol. 2001 May;64(1):51-68 12099922 - Eur J Neurol. 2002 Jul;9(4):377-82 15223298 - Neuropharmacology. 2004 Aug;47(2):195-204 15138435 - Neuropsychopharmacology. 2004 Jul;29(7):1378-85 19346128 - Bioorg Med Chem Lett. 2009 May 1;19(9):2409-12 17308038 - J Pharmacol Exp Ther. 2007 May;321(2):716-25 17514479 - Psychopharmacology (Berl). 2007 Sep;194(1):21-32 21088957 - Psychopharmacology (Berl). 2011 Apr;214(4):843-53 18311557 - Psychopharmacology (Berl). 2008 May;198(1):141-8 16107585 - Schizophr Bull. 2005 Oct;31(4):854-64 3854 - Science. 1976 Apr 30;192(4238):481-3 9067295 - J Pharmacol Exp Ther. 1997 Mar;280(3):1117-36 20630711 - Eur Neuropsychopharmacol. 2011 Apr;21(4):333-43 18524639 - Neurobiol Learn Mem. 2008 Sep;90(2):374-81 19713300 - Schizophr Bull. 2011 Mar;37(2):416-25 15159546 - Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8467-72 14985444 - J Neurosci. 2004 Feb 25;24(8):2013-26 16710314 - Neuropsychopharmacology. 2007 Jan;32(1):78-94 16987217 - Eur J Neurosci. 2006 Sep;24(5):1299-306 17767166 - Nat Med. 2007 Sep;13(9):1102-7 9062654 - Behav Brain Res. 1997 Feb;83(1-2):7-14 17116162 - Eur J Neurosci. 2006 Nov;24(10):2894-902 20957350 - Psychopharmacology (Berl). 2011 Mar;214(2):403-13 18771666 - Eur J Pharmacol. 2008 Oct 31;596(1-3):89-97 17069795 - Eur J Pharmacol. 2006 Dec 28;553(1-3):109-19 15219729 - Behav Brain Res. 2004 Aug 12;153(1):273-85 21303898 - Pharmacol Rev. 2011 Mar;63(1):182-217 8526975 - Neuropsychopharmacology. 1995 Aug;13(1):9-19 17019889 - EXS. 2006;98:185-205 12914983 - Brain Res. 2003 Sep 5;983(1-2):215-22 20012537 - Exp Brain Res. 2010 Apr;202(1):1-14 14662550 - Arch Gen Psychiatry. 2003 Dec;60(12):1187-92 1681750 - Am J Psychiatry. 1991 Nov;148(11):1474-86 15803162 - Nat Rev Neurosci. 2005 Apr;6(4):312-24 18753372 - J Neurosci. MJ Millan (2536_CR184) 2010; 13 G Tsai (2536_CR264) 1998; 44 I Kendall (2536_CR141) 2011; 213 C Pietá Dias (2536_CR212) 2007; 146 S Vijayraghavan (2536_CR271) 2007; 10 S Heckers (2536_CR114) 1998; 1 GW MacEwan (2536_CR167) 2001; 104 TH Moore (2536_CR190) 2007; 370 ED Levin (2536_CR153) 2006; 98 JM Singer (2536_CR250) 2009; 19 SB Taylor (2536_CR261) 2011; 224 WD Hirst (2536_CR119) 2006; 553 EV Sullivan (2536_CR258) 1992; 32 B Fagerlund (2536_CR87) 2007; 30 TU Woo (2536_CR283) 1997; 154 FG Boess (2536_CR26) 2007; 321 K Hashimoto (2536_CR111) 2008; 63 LE Hong (2536_CR121) 2011; 37 2536_CR73 T Damgaard (2536_CR61) 2011; 214 RP Ebstein (2536_CR82) 1996; 12 TA Jenkins (2536_CR131) 2009; 205 B Moghaddam (2536_CR189) 1998; 281 JA Lieberman (2536_CR161) 2009; 34 S Kapur (2536_CR137) 2001; 50 N Pitsikas (2536_CR213) 2003; 983 HR Quinn (2536_CR216) 2008; 33 CM O’Tuathaigh (2536_CR202) 2010; 35 DA Lewis (2536_CR158) 2005; 6 CM O’Tuathaigh (2536_CR201) 2006; 17 M Stelt van der (2536_CR268) 2003; 480 M Byrne (2536_CR42) 2007; 97 CS Myers (2536_CR193) 2004; 174 B Biton (2536_CR25) 2007; 32 LE Long (2536_CR165) 2010; 211 T Nagai (2536_CR195) 2009; 202 C Riemer (2536_CR224) 2003; 46 KA Radcliffe (2536_CR217) 1998; 18 JR Manns (2536_CR171) 2000; 97 JH Hu (2536_CR123) 2004; 15 JH Krystal (2536_CR146) 1999; 35 H Abe (2536_CR1) 2004; 356 D Vigano (2536_CR270) 2009; 12 JT Coyle (2536_CR55) 2006; 26 MA Dyer (2536_CR80) 2008; 102 PJ Harrison (2536_CR108) 2005; 10 JM Beaulieu (2536_CR19) 2011; 63 PH Botton (2536_CR28) 2010; 214 EC Warburton (2536_CR273) 2003; 38 SC Risch (2536_CR226) 2001; 7 LA Rothblat (2536_CR231) 1987; 101 RS Keefe (2536_CR139) 2007; 64 DD Rasmusson (2536_CR221) 2000; 115 B Grayson (2536_CR101) 2007; 184 SR Bradley (2536_CR30) 2010; 58 A Boultadakis (2536_CR29) 2010; 34 DK Hannesson (2536_CR106) 2004; 153 O Pascalis (2536_CR207) 2004; 42 C Puma (2536_CR215) 1998; 248 LA Dawson (2536_CR64) 2003; 110 K Ozawa (2536_CR205) 2006; 59 CM Reichel (2536_CR222) 2011; 36 PD Harvey (2536_CR109) 2000; 47 SE Hori (2536_CR122) 2007; 144 A Krivoy (2536_CR144) 2008; 18 Y Noda (2536_CR199) 2010; 13 A Higuera-Matas (2536_CR118) 2009; 93 R Freedman (2536_CR92) 2001; 105 N Simola (2536_CR248) 2008; 185 A Olincy (2536_CR200) 2006; 63 Z Li (2536_CR159) 2008; 596 J Ichikawa (2536_CR127) 2002; 956 O Tugal (2536_CR265) 2004; 7 JM Uslaner (2536_CR267) 2009; 57 S Kunitachi (2536_CR147) 2009; 1279 S Levine (2536_CR157) 1994; 19 DJ Johnson (2536_CR132) 2010; 20 BK Lipska (2536_CR162) 1993; 9 RE Clark (2536_CR52) 2007; 61 P Coyle (2536_CR56) 2009; 197 S Leonard (2536_CR152) 1998; 81 BD Winters (2536_CR276) 2005; 25 S Andreasson (2536_CR9) 1987; 2 CQ Chiu (2536_CR48) 2010; 30 JC Scott (2536_CR240) 2007; 17 AC Lahti (2536_CR148) 1995; 13 HY Lane (2536_CR150) 2010; 13 O Freudenreich (2536_CR94) 2005; 181 G Stober (2536_CR257) 2000; 67 2536_CR284 H Kamei (2536_CR136) 2006; 59 LJ Seidman (2536_CR244) 2003; 25 2536_CR289 PS Goldman-Rakic (2536_CR100) 1994; 6 JB Mitchell (2536_CR187) 1998; 97 BD Winters (2536_CR280) 2008; 32 B Marcos (2536_CR172) 2006; 24 TH Rammsayer (2536_CR220) 2001; 8 TJ Bussey (2536_CR38) 2005; 15 M Niwa (2536_CR198) 2011; 14 WB Scoville (2536_CR241) 1957; 20 JW Young (2536_CR288) 2009; 122 MF Green (2536_CR102) 2006; 67 R Schreiber (2536_CR237) 2007; 17 DG Mumby (2536_CR192) 1990; 18 NR Herring (2536_CR116) 2008; 199 JP Aggleton (2536_CR3) 2006; 10 LA Dawson (2536_CR66) 2001; 25 T Nagai (2536_CR194) 2007; 194 L Arseneault (2536_CR11) 2002; 325 BP Riley (2536_CR225) 2000; 96 S Heckers (2536_CR115) 2000; 48 LA Dawson (2536_CR65) 2000; 130 MH Chan (2536_CR47) 2008; 198 DN Jones (2536_CR133) 1995; 120 Y Guo (2536_CR105) 2009; 115 BD Winters (2536_CR278) 2004; 24 YC Chung (2536_CR49) 2009; 10 D Ibi (2536_CR126) 2010; 206 B Clancy (2536_CR50) 2001; 105 RS Ehrlichman (2536_CR83) 2009; 1294 L Duffy (2536_CR79) 2010; 170 VS Mattay (2536_CR175) 2003; 100 CM Adler (2536_CR2) 1999; 156 2536_CR262 B Aisa (2536_CR6) 2008; 154 SJ Bartko (2536_CR18) 2007; 27 C Dalman (2536_CR59) 2001; 179 2536_CR142 PF Sullivan (2536_CR259) 2003; 60 ED Levin (2536_CR154) 1995; 757 RA Cowell (2536_CR54) 2006; 26 MN Lima de (2536_CR69) 2005; 156 A Ennaceur (2536_CR84) 1988; 31 BK Lipska (2536_CR163) 2002; 27 JH Barnett (2536_CR17) 2007; 190 AP Yonelinas (2536_CR287) 2010; 20 ME Jackson (2536_CR129) 2004; 101 RS Keefe (2536_CR140) 2008; 33 SE Forwood (2536_CR88) 2005; 15 K Hashimoto (2536_CR110) 2005; 519 E Dere (2536_CR71) 2007; 31 R Greene (2536_CR103) 2001; 11 MJ Minzenberg (2536_CR185) 2004; 161 BD Winters (2536_CR277) 2005; 21 R Freedman (2536_CR91) 1995; 38 JM Gardiner (2536_CR98) 1988; 16 Z Zhang (2536_CR291) 2002; 115 P Sood (2536_CR255) 2010; 25 U Meyer (2536_CR182) 2010; 90 ML Woolley (2536_CR286) 2008; 19 JE Macor (2536_CR168) 2001; 11 TJ Bussey (2536_CR40) 2000; 111 D Malaspina (2536_CR170) 2004; 56 JR Clarke (2536_CR53) 2008; 90 S Shirazi-Southall (2536_CR247) 2002; 26 L Depatie (2536_CR70) 2002; 27 C Messier (2536_CR181) 1997; 67 E Bromley (2536_CR31) 2005; 31 RD McKee (2536_CR177) 1993; 19 ED Levin (2536_CR156) 1996; 15 N Bruin de (2536_CR67) 2006; 85 WD Hirst (2536_CR120) 2008; 325 CK Lieben (2536_CR160) 2005; 30 M Sarter (2536_CR234) 1997; 83 R Freedman (2536_CR90) 2001; 105 M Weiser (2536_CR274) 2004; 161 L Diaz-Mataix (2536_CR74) 2005; 25 P Singer (2536_CR249) 2007; 121 Y Shirayama (2536_CR246) 2007; 17 A Ennaceur (2536_CR86) 1997; 113 M Huang (2536_CR124) 2008; 33 TJ Bussey (2536_CR39) 1999; 19 J Leon de (2536_CR68) 2005; 76 GM Doniger (2536_CR78) 2002; 59 JG Harris (2536_CR107) 2004; 29 SL McLean (2536_CR180) 2011; 21 O Franberg (2536_CR89) 2009; 204 MW Brown (2536_CR34) 1998; 55 ML Woolley (2536_CR285) 2003; 170 P Morales (2536_CR191) 2010; 202 KB Baker (2536_CR13) 2002; 9 FW Lung (2536_CR166) 2009; 10 R Freedman (2536_CR93) 2008; 165 SN Haydar (2536_CR113) 2010; 53 A Bortolozzi (2536_CR27) 2007; 191 AI Hersi (2536_CR117) 1995; 15 TJ Raedler (2536_CR219) 2007; 12 Z Doleviczenyi (2536_CR77) 2008; 33 MJ Eacott (2536_CR81) 2005; 12 A Marutle (2536_CR173) 2001; 22 D Babovic (2536_CR12) 2008; 155 D Gaffan (2536_CR97) 1974; 86 PJ West (2536_CR275) 2009; 164 T Damgaard (2536_CR60) 2010; 207 EX Albuquerque (2536_CR8) 1997; 280 TW Robbins (2536_CR228) 2005; 31 H Rollema (2536_CR229) 1997; 338 S Akhondzadeh (2536_CR7) 2008; 32 AC McCreary (2536_CR176) 2007; 32 L Schiapparelli (2536_CR235) 2006; 50 HG Bernstein (2536_CR22) 1999; 10 F Papaleo (2536_CR206) 2008; 28 SN Dijk (2536_CR75) 1995; 115 CJ Dort Van (2536_CR269) 2009; 29 N Schroder (2536_CR238) 2003; 49 MV King (2536_CR143) 2009; 202 LM Devito (2536_CR72) 2010; 10 ST Patil (2536_CR208) 2007; 13 TA Hauser (2536_CR112) 2009; 78 T Steckler (2536_CR256) 1995; 67 HT Ito (2536_CR128) 2010; 24 A Sambeth (2536_CR232) 2007; 572 JC Crabbe (2536_CR57) 1999; 284 DC Goff (2536_CR99) 2005; 179 HY Lane (2536_CR149) 2006; 60 P Zanassi (2536_CR290) 2001; 276 BD Winters (2536_CR281) 2010; 93 R Roncarati (2536_CR230) 2009; 329 L Maia (2536_CR169) 2002; 9 JH Krystal (2536_CR145) 1994; 51 SM Smith (2536_CR253) 2009; 328 E Tulving (2536_CR266) 1985; 40 S Nemanic (2536_CR196) 2004; 24 A Shiina (2536_CR245) 2010; 9 K Ritchie (2536_CR227) 2007; 69 CM Hultman (2536_CR125) 1999; 318 CE McKibben (2536_CR178) 2010; 208 F Sams-Dodd (2536_CR233) 1997; 132 RW Buchanan (2536_CR36) 2003; 59 P Seeman (2536_CR242) 1975; 188 RC Smith (2536_CR251) 2006; 31 J Arnt (2536_CR10) 2010; 13 M Mishkin (2536_CR186) 1975; 1 MW Brown (2536_CR33) 2002; 357 S Snigdha (2536_CR254) 2010; 214 2536_CR218 MH Schubert (2536_CR239) 2006; 60 I Creese (2536_CR58) 1976; 192 TL Wallace (2536_CR272) 2011; 336 F Liu (2536_CR164) 2008; 327 A Carlsson (2536_CR46) 1963; 20 A Ennaceur (2536_CR85) 1996; 80 BD Winters (2536_CR279) 2006; 26 PV Massey (2536_CR174) 2001; 14 SW Lee (2536_CR151) 2007; 22 M Schneider (2536_CR236) 2003; 28 RW Buchanan (2536_CR37) 2008; 165 CA Jones (2536_CR134) 2010; 214 MJ Millan (2536_CR183) 2008; 324 M Bianchi (2536_CR24) 2006; 24 2536_CR204 M Nilsson (2536_CR197) 2007; 149 P Pichat (2536_CR211) 2007; 32 RC Smith (2536_CR252) 2009; 110 I Barna (2536_CR16) 2007; 18 GR Barker (2536_CR15) 2006; 13 KJ Friston (2536_CR96) 1992; 115 SJ Ballaz (2536_CR14) 2007; 149 JI Friedman (2536_CR95) 2002; 51 DC Javitt (2536_CR130) 2009; 35 LO Pereira (2536_CR210) 2008; 1218 2536_CR41 ED Levin (2536_CR155) 1998; 138 JM Danion (2536_CR62) 2007; 52 S Sydserff (2536_CR260) 2009; 78 L Dixon (2536_CR76) 1991; 148 J Karasawa (2536_CR138) 2008; 186 AS Brown (2536_CR32) 2006; 32 M Pelletier (2536_CR209) 2005; 74 JP Aggleton (2536_CR5) 1997; 43 HC Grunze (2536_CR104) 1996; 16 M Carli (2536_CR45) 1997; 774 AD Kalechstein (2536_CR135) 2003; 15 AS Brown (2536_CR35) 2004; 61 J Camarasa (2536_CR44) 2010; 62 SL McLean (2536_CR179) 2009; 206 AM Belcher (2536_CR20) 2008; 33 RE Clark (2536_CR51) 2000; 20 2536_CR23 WH Overman (2536_CR203) 1993; 26 H Prast (2536_CR214) 2001; 64 DG Wishka (2536_CR282) 2006; 49 ME Calkins (2536_CR43) 2005; 162 JP Aggleton (2536_CR4) 1986; 19 ES Mitchell (2536_CR188) 2005; 108 P Seeman (2536_CR243) 1993; 365 V Tretter (2536_CR263) 2009; 106 W Riedel (2536_CR223) 1995; 122 2536_CR21 KL Davis (2536_CR63) 1991; 148 |
References_xml | – volume: 56 start-page: 931 year: 2004 end-page: 937 ident: CR170 article-title: Resting neural activity distinguishes subgroups of schizophrenia patients publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2004.09.013 contributor: fullname: Van Heertum – volume: 325 start-page: 134 year: 2008 end-page: 145 ident: CR120 article-title: Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexan e carboxamide (WAY-101405) publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.107.133082 contributor: fullname: Schechter – volume: 188 start-page: 1217 year: 1975 end-page: 1219 ident: CR242 article-title: Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons publication-title: Science doi: 10.1126/science.1145194 contributor: fullname: Lee – volume: 202 start-page: 1 year: 2010 end-page: 14 ident: CR191 article-title: Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats publication-title: Exp Brain Res doi: 10.1007/s00221-009-2103-z contributor: fullname: Herrera-Marschitz – volume: 7 start-page: 105 year: 2001 end-page: 110 ident: CR226 article-title: A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: functional MRI correlates publication-title: Neurocase doi: 10.1093/neucas/7.2.105 contributor: fullname: George – volume: 67 start-page: 1201 year: 2000 end-page: 1207 ident: CR257 article-title: Splitting schizophrenia: periodic catatonia-susceptibility locus on chromosome 15q15 publication-title: Am J Hum Genet contributor: fullname: Beckmann – volume: 113 start-page: 509 year: 1997 end-page: 519 ident: CR86 article-title: Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix publication-title: Exp Brain Res doi: 10.1007/PL00005603 contributor: fullname: Aggleton – volume: 10 start-page: 210 year: 2010 end-page: 222 ident: CR72 article-title: Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology publication-title: Genes Brain Behav contributor: fullname: Eichenbaum – volume: 24 start-page: 1299 year: 2006 end-page: 1306 ident: CR172 article-title: Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2006.05003.x contributor: fullname: Ramirez – volume: 214 start-page: 843 year: 2010 end-page: 853 ident: CR254 article-title: Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D(1) receptor mechanism publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-010-2091-5 contributor: fullname: Neill – volume: 101 start-page: 8467 year: 2004 end-page: 8472 ident: CR129 article-title: NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0308455101 contributor: fullname: Moghaddam – volume: 20 start-page: 1178 year: 2010 end-page: 1194 ident: CR287 article-title: Recollection and familiarity: examining controversial assumptions and new directions publication-title: Hippocampus doi: 10.1002/hipo.20864 contributor: fullname: Koen – volume: 11 start-page: 569 year: 2001 end-page: 577 ident: CR103 article-title: Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia publication-title: Hippocampus doi: 10.1002/hipo.1072 contributor: fullname: Greene – volume: 165 start-page: 82 year: 2008 end-page: 89 ident: CR37 article-title: Galantamine for the treatment of cognitive impairments in people with schizophrenia publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2007.07050724 contributor: fullname: McMahon – volume: 33 start-page: 1217 year: 2008 end-page: 1228 ident: CR140 article-title: Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301499 contributor: fullname: Goldman – volume: 111 start-page: 187 year: 2000 end-page: 202 ident: CR40 article-title: Distinct patterns of behavioural impairments resulting from fornix transection or neurotoxic lesions of the perirhinal and postrhinal cortices in the rat publication-title: Behav Brain Res doi: 10.1016/S0166-4328(00)00155-8 contributor: fullname: Aggleton – volume: 31 start-page: 954 year: 2005 end-page: 961 ident: CR31 article-title: A collaborative approach to targeted treatment development for schizophrenia: a qualitative evaluation of the NIMH-MATRICS project publication-title: Schizophr Bull doi: 10.1093/schbul/sbi059 contributor: fullname: Bromley – volume: 32 start-page: 1 year: 2007 end-page: 16 ident: CR25 article-title: SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301189 contributor: fullname: Scatton – volume: 42 start-page: 1293 year: 2004 end-page: 1300 ident: CR207 article-title: Visual paired comparison performance is impaired in a patient with selective hippocampal lesions and relatively intact item recognition publication-title: Neuropsychologia doi: 10.1016/j.neuropsychologia.2004.03.005 contributor: fullname: Mayes – volume: 329 start-page: 459 year: 2009 end-page: 468 ident: CR230 article-title: Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.150094 contributor: fullname: Terstappen – volume: 81 start-page: 308 year: 1998 end-page: 312 ident: CR152 article-title: Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH Genetics Initiative publication-title: Am J Med Genet doi: 10.1002/(SICI)1096-8628(19980710)81:4<308::AID-AJMG6>3.0.CO;2-P contributor: fullname: Freedman – volume: 138 start-page: 217 year: 1998 end-page: 230 ident: CR155 article-title: Nicotinic acetylcholine involvement in cognitive function in animals publication-title: Psychopharmacology (Berl) doi: 10.1007/s002130050667 contributor: fullname: Simon – volume: 16 start-page: 446 year: 1988 end-page: 451 ident: CR98 article-title: Recognition failures and free-recall failures: implications for the relation between recall and recognition publication-title: Mem Cognit doi: 10.3758/BF03214225 contributor: fullname: Gardiner – volume: 60 start-page: 645 year: 2006 end-page: 649 ident: CR149 article-title: Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.04.005 contributor: fullname: Tsai – volume: 19 start-page: 133 year: 1986 end-page: 146 ident: CR4 article-title: The effects of hippocampal lesions upon spatial and non-spatial tests of working memory publication-title: Behav Brain Res doi: 10.1016/0166-4328(86)90011-2 contributor: fullname: Rawlins – volume: 100 start-page: 6186 year: 2003 end-page: 6191 ident: CR175 article-title: Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0931309100 contributor: fullname: Weinberger – volume: 9 start-page: 67 year: 1993 end-page: 75 ident: CR162 article-title: Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia publication-title: Neuropsychopharmacology contributor: fullname: Weinberger – volume: 46 start-page: 1273 year: 2003 end-page: 1276 ident: CR224 article-title: Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist publication-title: J Med Chem doi: 10.1021/jm021085c contributor: fullname: Bos – volume: 24 start-page: 2013 year: 2004 end-page: 2026 ident: CR196 article-title: The hippocampal/parahippocampal regions and recognition memory: insights from visual paired comparison versus object-delayed nonmatching in monkeys publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3763-03.2004 contributor: fullname: Bachevalier – volume: 59 start-page: 546 year: 2006 end-page: 554 ident: CR205 article-title: Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.07.031 contributor: fullname: Iyo – volume: 202 start-page: 315 year: 2009 end-page: 328 ident: CR195 article-title: Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1240-6 contributor: fullname: Nabeshima – volume: 60 start-page: 530 year: 2006 end-page: 533 ident: CR239 article-title: Galantamine improves cognition in schizophrenic patients stabilized on risperidone publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.04.006 contributor: fullname: Hicks – volume: 204 start-page: 251 year: 2009 end-page: 264 ident: CR89 article-title: Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1456-5 contributor: fullname: Svensson – volume: 13 start-page: 178 year: 2006 end-page: 186 ident: CR15 article-title: A temporally distinct role for group I and group II metabotropic glutamate receptors in object recognition memory publication-title: Learn Mem doi: 10.1101/lm.77806 contributor: fullname: Warburton – volume: 78 start-page: 803 year: 2009 end-page: 812 ident: CR112 article-title: TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2009.05.030 contributor: fullname: Bencherif – volume: 356 start-page: 191 year: 2004 end-page: 194 ident: CR1 article-title: Perirhinal N-methyl-D-aspartate and muscarinic systems participate in object recognition in rats publication-title: Neurosci Lett doi: 10.1016/j.neulet.2003.11.049 contributor: fullname: Iwasaki – volume: 31 start-page: 673 year: 2007 end-page: 704 ident: CR71 article-title: The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2007.01.005 contributor: fullname: De Souza Silva – volume: 25 start-page: 281 year: 2007 end-page: 290 ident: CR262 article-title: Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1) publication-title: Eur J Neurosci contributor: fullname: Del Rio – volume: 206 start-page: 403 year: 2009 end-page: 414 ident: CR179 article-title: Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-009-1618-0 contributor: fullname: Neill – volume: 12 start-page: 232 year: 2007 end-page: 246 ident: CR219 article-title: Towards a muscarinic hypothesis of schizophrenia publication-title: Mol Psychiatr contributor: fullname: Dean – volume: 20 start-page: 5434 year: 2010 end-page: 5438 ident: CR132 article-title: The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists publication-title: Bioorg Med Chem Lett doi: 10.1016/j.bmcl.2010.07.097 contributor: fullname: Brown – volume: 214 start-page: 254 year: 2010 end-page: 259 ident: CR28 article-title: Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice publication-title: Behav Brain Res doi: 10.1016/j.bbr.2010.05.034 contributor: fullname: Porciuncula – volume: 44 start-page: 1081 year: 1998 end-page: 1089 ident: CR264 article-title: D-serine added to antipsychotics for the treatment of schizophrenia publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(98)00279-0 contributor: fullname: Coyle – volume: 47 start-page: 195 year: 2004 end-page: 204 ident: CR142 article-title: 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation--an effect sensitive to NMDA receptor antagonism publication-title: Neuropharmacology contributor: fullname: Fone – volume: 32 start-page: 78 year: 2007 end-page: 94 ident: CR176 article-title: SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301098 contributor: fullname: Kruse – volume: 96 start-page: 196 year: 2000 end-page: 201 ident: CR225 article-title: Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families publication-title: Am J Med Genet doi: 10.1002/(SICI)1096-8628(20000403)96:2<196::AID-AJMG15>3.0.CO;2-4 contributor: fullname: Murray – volume: 108 start-page: 320 year: 2005 end-page: 333 ident: CR188 article-title: 5-HT6 receptors: a novel target for cognitive enhancement publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2005.05.001 contributor: fullname: Neumaier – volume: 35 start-page: 193 year: 2009 end-page: 200 ident: CR73 article-title: GSK3β, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at serine-9 publication-title: Neurobiol Dis contributor: fullname: Leuven – volume: 21 start-page: 2263 year: 2005 end-page: 2270 ident: CR277 article-title: Removal of cholinergic input to perirhinal cortex disrupts object recognition but not spatial working memory in the rat publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2005.04055.x contributor: fullname: Bussey – volume: 13 start-page: 1021 year: 2010 end-page: 1033 ident: CR10 article-title: Lu AE58054, a 5-HT(6) antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145710000659 contributor: fullname: Witten – volume: 115 start-page: 41 year: 2009 end-page: 49 ident: CR105 article-title: Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand publication-title: Schizophr Res doi: 10.1016/j.schres.2009.08.002 contributor: fullname: Zhen – volume: 50 start-page: 873 year: 2001 end-page: 883 ident: CR137 article-title: Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(01)01251-3 contributor: fullname: Remington – volume: 104 start-page: 469 year: 2001 end-page: 472 ident: CR167 article-title: Donepezil in schizophrenia—is it helpful? An experimental design case study publication-title: Acta Psychiatr Scand doi: 10.1046/j.0001-690X.2001.acp1c008d.x contributor: fullname: Wrixon – volume: 33 start-page: 1113 year: 2008 end-page: 1126 ident: CR216 article-title: Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301475 contributor: fullname: McGregor – volume: 10 start-page: 147 year: 2009 ident: CR166 article-title: Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case–control study publication-title: BMC Med Genet doi: 10.1186/1471-2350-10-147 contributor: fullname: Tzeng – volume: 11 start-page: 319 year: 2001 end-page: 321 ident: CR168 article-title: The 5-HT3 antagonist tropisetron (ICS 205–930) is a potent and selective alpha7 nicotinic receptor partial agonist publication-title: Bioorg Med Chem Lett doi: 10.1016/S0960-894X(00)00670-3 contributor: fullname: Gordon – volume: 184 start-page: 31 year: 2007 end-page: 38 ident: CR101 article-title: Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat publication-title: Behav Brain Res doi: 10.1016/j.bbr.2007.06.012 contributor: fullname: Neill – volume: 26 start-page: 583 year: 2002 end-page: 594 ident: CR247 article-title: Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(01)00400-6 contributor: fullname: Nomikos – volume: 130 start-page: 23 year: 2000 end-page: 26 ident: CR65 article-title: In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0703288 contributor: fullname: Li – volume: 29 start-page: 871 year: 2009 end-page: 881 ident: CR269 article-title: Adenosine A(1) and A(2A) receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4111-08.2009 contributor: fullname: Lydic – volume: 30 start-page: 3 year: 2007 end-page: 12 ident: CR87 article-title: Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study publication-title: Clin Neuropharmacol doi: 10.1097/01.WNF.0000240940.67241.F6 contributor: fullname: Glenthoj – volume: 24 start-page: 930 year: 2010 end-page: 941 ident: CR128 article-title: Maternal immune activation alters nonspatial information processing in the hippocampus of the adult offspring publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2010.03.004 contributor: fullname: Patterson – volume: 60 start-page: 1187 year: 2003 end-page: 1192 ident: CR259 article-title: Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.60.12.1187 contributor: fullname: Neale – volume: 211 start-page: 277 year: 2010 end-page: 289 ident: CR165 article-title: A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-010-1896-6 contributor: fullname: Karl – volume: 13 start-page: 1102 year: 2007 end-page: 1107 ident: CR208 article-title: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial publication-title: Nat Med doi: 10.1038/nm1632 contributor: fullname: Schoepp – volume: 63 start-page: 182 year: 2011 end-page: 217 ident: CR19 article-title: The physiology, signaling and pharmacology of dopamine receptors publication-title: Pharmacol Rev doi: 10.1124/pr.110.002642 contributor: fullname: Gainetdinov – volume: 179 start-page: 403 year: 2001 end-page: 408 ident: CR59 article-title: Signs of asphyxia at birth and risk of schizophrenia. Population-based case–control study publication-title: Br J Psychiatry doi: 10.1192/bjp.179.5.403 contributor: fullname: Allebeck – volume: 9 start-page: 377 year: 2002 end-page: 382 ident: CR169 article-title: Does caffeine intake protect from Alzheimer’s disease? publication-title: Eur J Neurol doi: 10.1046/j.1468-1331.2002.00421.x contributor: fullname: de Mendonca – volume: 38 start-page: 987 year: 2003 end-page: 996 ident: CR273 article-title: Cholinergic neurotransmission is essential for perirhinal cortical plasticity and recognition memory publication-title: Neuron doi: 10.1016/S0896-6273(03)00358-1 contributor: fullname: Brown – volume: 13 start-page: 9 year: 1995 end-page: 19 ident: CR148 article-title: Subanesthetic doses of ketamine stimulate psychosis in schizophrenia publication-title: Neuropsychopharmacology doi: 10.1016/0893-133X(94)00131-I contributor: fullname: Tamminga – volume: 102 start-page: 88 year: 2008 end-page: 95 ident: CR80 article-title: High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia publication-title: Schizophr Res doi: 10.1016/j.schres.2007.12.491 contributor: fullname: Evins – volume: 59 start-page: 1011 year: 2002 end-page: 1020 ident: CR78 article-title: Impaired visual object recognition and dorsal/ventral stream interaction in schizophrenia publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.59.11.1011 contributor: fullname: Javitt – volume: 26 start-page: 345 year: 1993 end-page: 357 ident: CR203 article-title: A comparison of children’s performance on two recognition memory tasks: delayed nonmatch-to-sample versus visual paired-comparison publication-title: Dev Psychobiol doi: 10.1002/dev.420260605 contributor: fullname: Drew – volume: 115 start-page: 819 year: 2002 end-page: 823 ident: CR291 article-title: A selective reduction in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia patients publication-title: Chin Med J (Engl) contributor: fullname: Reynolds – volume: 144 start-page: 1 year: 2007 end-page: 7 ident: CR122 article-title: Darbepoetin alfa (Aranesp) improves recognition memory in adult rats that have sustained bilateral ventral hippocampal lesions as neonates or young adults publication-title: Neuroscience doi: 10.1016/j.neuroscience.2006.09.041 contributor: fullname: Robertson – volume: 276 start-page: 11487 year: 2001 end-page: 11495 ident: CR290 article-title: cAMP-dependent protein kinase induces cAMP-response element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons publication-title: J Biol Chem doi: 10.1074/jbc.M007631200 contributor: fullname: Schinelli – volume: 122 start-page: 158 year: 1995 end-page: 168 ident: CR223 article-title: Caffeine attenuates scopolamine-induced memory impairment in humans publication-title: Psychopharmacology (Berl) doi: 10.1007/BF02246090 contributor: fullname: Jolles – volume: 224 start-page: 223 year: 2011 end-page: 232 ident: CR261 article-title: Sex-specific neuroendocrine and behavioral phenotypes in hypomorphic Type II Neuregulin 1 rats publication-title: Behav Brain Res doi: 10.1016/j.bbr.2011.05.008 contributor: fullname: Koenig – volume: 51 start-page: 199 year: 1994 end-page: 214 ident: CR145 article-title: Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1994.03950030035004 contributor: fullname: Charney – volume: 43 start-page: 279 year: 1997 end-page: 287 ident: CR5 article-title: Extensive cytotoxic lesions involving both the rhinal cortices and area TE impair recognition but spare spatial alternation in the rat publication-title: Brain Res Bull doi: 10.1016/S0361-9230(97)00007-5 contributor: fullname: Bussey – volume: 101 start-page: 587 year: 1987 end-page: 590 ident: CR231 article-title: Short-term object recognition memory in the rat: nonmatching with trial-unique junk stimuli publication-title: Behav Neurosci doi: 10.1037/0735-7044.101.4.587 contributor: fullname: Hayes – ident: CR21 – volume: 105 start-page: 7 year: 2001 end-page: 17 ident: CR50 article-title: Translating developmental time across mammalian species publication-title: Neuroscience doi: 10.1016/S0306-4522(01)00171-3 contributor: fullname: Finlay – volume: 24 start-page: 5901 year: 2004 end-page: 5908 ident: CR278 article-title: Double dissociation between the effects of peri-postrhinal cortex and hippocampal lesions on tests of object recognition and spatial memory: heterogeneity of function within the temporal lobe publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1346-04.2004 contributor: fullname: Bussey – volume: 122 start-page: 150 year: 2009 end-page: 202 ident: CR288 article-title: Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2009.02.004 contributor: fullname: Geyer – volume: 156 start-page: 1646 year: 1999 end-page: 1649 ident: CR2 article-title: Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia publication-title: Am J Psychiatry contributor: fullname: Breier – volume: 74 start-page: 233 year: 2005 end-page: 252 ident: CR209 article-title: Cognitive and clinical moderators of recognition memory in schizophrenia: a meta-analysis publication-title: Schizophr Res doi: 10.1016/j.schres.2004.08.017 contributor: fullname: Lepage – volume: 115 start-page: 367 issue: Pt 2 year: 1992 end-page: 382 ident: CR96 article-title: The left medial temporal region and schizophrenia. A PET study publication-title: Brain doi: 10.1093/brain/115.2.367 contributor: fullname: Frackowiak – volume: 106 start-page: 20039 year: 2009 end-page: 20044 ident: CR263 article-title: Deficits in spatial memory correlate with modified {gamma}-aminobutyric acid type A receptor tyrosine phosphorylation in the hippocampus publication-title: Proc Natl Acad Sci USA contributor: fullname: Moss – volume: 115 start-page: 1169 year: 1995 end-page: 1174 ident: CR75 article-title: NMDA-induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5-HT1A antagonist publication-title: Br J Pharmacol contributor: fullname: Bowen – volume: 26 start-page: 12186 year: 2006 end-page: 12197 ident: CR54 article-title: Why does brain damage impair memory? A connectionist model of object recognition memory in perirhinal cortex publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2818-06.2006 contributor: fullname: Saksida – volume: 52 start-page: 693 year: 2007 end-page: 701 ident: CR62 article-title: Functional mechanisms of episodic memory impairment in schizophrenia publication-title: Can J Psychiatr contributor: fullname: Berna – volume: 199 start-page: 637 year: 2008 end-page: 650 ident: CR116 article-title: Effect of +−methamphetamine on path integration learning, novel object recognition, and neurotoxicity in rats publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1183-y contributor: fullname: Williams – volume: 154 start-page: 1218 year: 2008 end-page: 1226 ident: CR6 article-title: Effects of maternal separation on hypothalamic-pituitary-adrenal responses, cognition and vulnerability to stress in adult female rats publication-title: Neuroscience doi: 10.1016/j.neuroscience.2008.05.011 contributor: fullname: Ramirez – volume: 27 start-page: 1056 year: 2002 end-page: 1070 ident: CR70 article-title: Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(02)00372-X contributor: fullname: Lal – volume: 64 start-page: 51 year: 2001 end-page: 68 ident: CR214 article-title: Nitric oxide as modulator of neuronal function publication-title: Prog Neurobiol doi: 10.1016/S0301-0082(00)00044-7 contributor: fullname: Philippu – volume: 19 start-page: 765 year: 2008 end-page: 776 ident: CR286 article-title: Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat publication-title: Behav Pharmacol doi: 10.1097/FBP.0b013e32831c3b06 contributor: fullname: Dawson – volume: 63 start-page: 92 year: 2008 end-page: 97 ident: CR111 article-title: Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2007.04.034 contributor: fullname: Iyo – volume: 28 start-page: 1760 year: 2003 end-page: 1769 ident: CR236 article-title: Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300225 contributor: fullname: Koch – volume: 156 start-page: 139 year: 2005 end-page: 143 ident: CR69 article-title: Pre- or post-training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats publication-title: Behav Brain Res doi: 10.1016/j.bbr.2004.05.016 contributor: fullname: Schröder – volume: 67 start-page: e12 year: 2006 ident: CR102 article-title: Cognitive impairment and functional outcome in schizophrenia and bipolar disorder publication-title: J Clin Psychiatr doi: 10.4088/JCP.1006e12 contributor: fullname: Green – volume: 93 start-page: 221 year: 2010 end-page: 228 ident: CR281 article-title: Muscimol, AP5, or scopolamine infused into perirhinal cortex impairs two-choice visual discrimination learning in rats publication-title: Neurobiol Learn Mem doi: 10.1016/j.nlm.2009.10.002 contributor: fullname: Bussey – volume: 29 start-page: 1378 year: 2004 end-page: 1385 ident: CR107 article-title: Effects of nicotine on cognitive deficits in schizophrenia publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300450 contributor: fullname: Freedman – volume: 35 start-page: 1059 year: 2009 end-page: 1064 ident: CR130 article-title: Sensory processing in schizophrenia: neither simple nor intact publication-title: Schizophr Bull doi: 10.1093/schbul/sbp110 contributor: fullname: Javitt – volume: 50 start-page: 897 year: 2006 end-page: 907 ident: CR235 article-title: Opposing effects of AMPA and 5-HT1A receptor blockade on passive avoidance and object recognition performance: correlation with AMPA receptor subunit expression in rat hippocampus publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2006.02.005 contributor: fullname: Frechilla – volume: 164 start-page: 692 year: 2009 end-page: 701 ident: CR275 article-title: Activation of the 5-HT(6) receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus publication-title: Neuroscience doi: 10.1016/j.neuroscience.2009.07.061 contributor: fullname: Schaffhauser – volume: 155 start-page: 1021 year: 2008 end-page: 1029 ident: CR12 article-title: Phenotypic characterization of cognition and social behavior in mice with heterozygous versus homozygous deletion of catechol-O-methyltransferase publication-title: Neuroscience doi: 10.1016/j.neuroscience.2008.07.006 contributor: fullname: Waddington – volume: 1294 start-page: 116 year: 2009 end-page: 127 ident: CR83 article-title: Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions publication-title: Brain Res doi: 10.1016/j.brainres.2009.07.065 contributor: fullname: Siegel – volume: 208 start-page: 132 year: 2010 end-page: 136 ident: CR178 article-title: Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat publication-title: Behav Brain Res doi: 10.1016/j.bbr.2009.11.018 contributor: fullname: Reynolds – volume: 31 start-page: 854 year: 2005 end-page: 864 ident: CR228 article-title: Synthesizing schizophrenia: a bottom-up, symptomatic approach publication-title: Schizophr Bull doi: 10.1093/schbul/sbi044 contributor: fullname: Robbins – volume: 214 start-page: 269 year: 2010 end-page: 283 ident: CR134 article-title: The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-010-1931-7 contributor: fullname: Fone – volume: 6 start-page: 348 year: 1994 end-page: 357 ident: CR100 article-title: Working memory dysfunction in schizophrenia publication-title: J Neuropsychiatry Clin Neurosci contributor: fullname: Goldman-Rakic – volume: 284 start-page: 1670 year: 1999 end-page: 1672 ident: CR57 article-title: Genetics of mouse behavior: interactions with laboratory environment publication-title: Science doi: 10.1126/science.284.5420.1670 contributor: fullname: Dudek – volume: 2 start-page: 1483 year: 1987 end-page: 1486 ident: CR9 article-title: Cannabis and schizophrenia. A longitudinal study of Swedish conscripts publication-title: Lancet doi: 10.1016/S0140-6736(87)92620-1 contributor: fullname: Rydberg – volume: 19 start-page: 495 year: 1999 end-page: 502 ident: CR39 article-title: Functionally dissociating aspects of event memory: the effects of combined perirhinal and postrhinal cortex lesions on object and place memory in the rat publication-title: J Neurosci contributor: fullname: Aggleton – volume: 553 start-page: 109 year: 2006 end-page: 119 ident: CR119 article-title: SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2006.09.049 contributor: fullname: Upton – volume: 161 start-page: 116 year: 2004 end-page: 124 ident: CR185 article-title: Association of anticholinergic load with impairment of complex attention and memory in schizophrenia publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.161.1.116 contributor: fullname: Vinogradov – volume: 1 start-page: 326 year: 1975 end-page: 334 ident: CR186 article-title: An analysis of short-term visual memory in the monkey publication-title: J Exp Psychol Anim Behav Process doi: 10.1037/0097-7403.1.4.326 contributor: fullname: Delacour – volume: 12 start-page: 599 year: 2009 end-page: 614 ident: CR270 article-title: Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145708009371 contributor: fullname: Parolaro – volume: 36 start-page: 1501 year: 2006 end-page: 1514 ident: CR204 article-title: Precursors and prodromata of schizophrenia: findings from the Edinburgh High Risk Study and their literature context publication-title: Psychol Med contributor: fullname: Johnstone – volume: 19 start-page: 397 year: 1993 end-page: 404 ident: CR177 article-title: On the development of declarative memory publication-title: J Exp Psychol Learn Mem Cogn doi: 10.1037/0278-7393.19.2.397 contributor: fullname: Squire – volume: 35 start-page: S35 issue: Suppl year: 1999 end-page: S49 ident: CR146 article-title: Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients publication-title: Schizophr Res doi: 10.1016/S0920-9964(98)00162-5 contributor: fullname: Petrakis – volume: 33 start-page: 1453 year: 2008 end-page: 1463 ident: CR20 article-title: Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301510 contributor: fullname: Marshall – volume: 318 start-page: 421 year: 1999 end-page: 426 ident: CR125 article-title: Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case–control study publication-title: BMJ doi: 10.1136/bmj.318.7181.421 contributor: fullname: Cnattingius – volume: 26 start-page: 9520 year: 2006 end-page: 9529 ident: CR279 article-title: Paradoxical facilitation of object recognition memory after infusion of scopolamine into perirhinal cortex: implications for cholinergic system function publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2319-06.2006 contributor: fullname: Bussey – volume: 18 start-page: 7075 year: 1998 end-page: 7083 ident: CR217 article-title: Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission publication-title: J Neurosci contributor: fullname: Dani – volume: 17 start-page: 275 year: 2007 end-page: 297 ident: CR240 article-title: Neurocognitive effects of methamphetamine: a critical review and meta-analysis publication-title: Neuropsychol Rev doi: 10.1007/s11065-007-9031-0 contributor: fullname: Grant – volume: 105 start-page: 655 year: 2001 end-page: 657 ident: CR90 article-title: Genetic linkage to schizophrenia at chromosome 15q14 publication-title: Am J Med Genet doi: 10.1002/ajmg.1548 contributor: fullname: Leonard – volume: 15 start-page: 215 year: 2003 end-page: 220 ident: CR135 article-title: Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence publication-title: J Neuropsychiatry Clin Neurosci doi: 10.1176/appi.neuropsych.15.2.215 contributor: fullname: Green – volume: 14 start-page: 459 year: 2011 end-page: 477 ident: CR198 article-title: Vulnerability in early life to changes in the rearing environment plays a crucial role in the aetiopathology of psychiatric disorders publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145710001239 contributor: fullname: Nabeshima – volume: 28 start-page: 8709 year: 2008 end-page: 8723 ident: CR206 article-title: Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2077-08.2008 contributor: fullname: Chen – volume: 10 start-page: 455 year: 2006 end-page: 463 ident: CR3 article-title: Interleaving brain systems for episodic and recognition memory publication-title: Trends Cogn Sci doi: 10.1016/j.tics.2006.08.003 contributor: fullname: Brown – volume: 191 start-page: 745 year: 2007 end-page: 758 ident: CR27 article-title: In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-007-0698-y contributor: fullname: Artigas – volume: 90 start-page: 374 year: 2008 end-page: 381 ident: CR53 article-title: Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory publication-title: Neurobiol Learn Mem doi: 10.1016/j.nlm.2008.04.009 contributor: fullname: Cammarota – volume: 149 start-page: 192 year: 2007 end-page: 202 ident: CR14 article-title: The 5-HT7 receptor: role in novel object discrimination and relation to novelty-seeking behavior publication-title: Neuroscience doi: 10.1016/j.neuroscience.2007.07.043 contributor: fullname: Watson – volume: 16 start-page: 2034 year: 1996 end-page: 2043 ident: CR104 article-title: NMDA-dependent modulation of CA1 local circuit inhibition publication-title: J Neurosci contributor: fullname: Greene – volume: 206 start-page: 32 year: 2010 end-page: 37 ident: CR126 article-title: Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood publication-title: Behav Brain Res doi: 10.1016/j.bbr.2009.08.027 contributor: fullname: Yamada – volume: 154 start-page: 1013 year: 1997 end-page: 1015 ident: CR283 article-title: Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons publication-title: Am J Psychiatry contributor: fullname: Lewis – volume: 12 start-page: 78 year: 1996 end-page: 80 ident: CR82 article-title: Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking publication-title: Nat Genet doi: 10.1038/ng0196-78 contributor: fullname: Belmaker – volume: 90 start-page: 285 year: 2010 end-page: 326 ident: CR182 article-title: Epidemiology-driven neurodevelopmental animal models of schizophrenia publication-title: Prog Neurobiol doi: 10.1016/j.pneurobio.2009.10.018 contributor: fullname: Feldon – volume: 57 start-page: 531 year: 2009 end-page: 538 ident: CR267 article-title: Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2009.07.022 contributor: fullname: Hutson – volume: 55 start-page: 149 year: 1998 end-page: 189 ident: CR34 article-title: Recognition memory: neuronal substrates of the judgement of prior occurrence publication-title: Prog Neurobiol doi: 10.1016/S0301-0082(98)00002-1 contributor: fullname: Xiang – volume: 357 start-page: 1083 year: 2002 end-page: 1095 ident: CR33 article-title: Evidence concerning how neurons of the perirhinal cortex may effect familiarity discrimination publication-title: Philos Trans R Soc Lond B Biol Sci doi: 10.1098/rstb.2002.1097 contributor: fullname: Bashir – volume: 15 start-page: 429 year: 1996 end-page: 436 ident: CR156 article-title: Nicotine–haloperidol interactions and cognitive performance in schizophrenics publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(96)00018-8 contributor: fullname: McEvoy – volume: 15 start-page: 9 year: 2004 end-page: 12 ident: CR123 article-title: Cognitive impairment in mice over-expressing gamma-aminobutyric acid transporter 1 (GAT1) publication-title: Neuroreport doi: 10.1097/00001756-200401190-00003 contributor: fullname: Guo – volume: 19 start-page: 143 year: 1994 end-page: 153 ident: CR157 article-title: Pituitary–adrenal and interleukin-6 responses to recombinant interleukin-1 in neonatal rats publication-title: Psychoneuroendocrinology doi: 10.1016/0306-4530(94)90004-3 contributor: fullname: Tilders – volume: 40 start-page: 385 year: 1985 end-page: 398 ident: CR266 article-title: How many memory systems are there? publication-title: Am Psychol doi: 10.1037/0003-066X.40.4.385 contributor: fullname: Tulving – volume: 185 start-page: 595 year: 2008 end-page: 601 ident: CR248 article-title: Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats publication-title: Exp Brain Res doi: 10.1007/s00221-007-1186-7 contributor: fullname: Herrera-Marschitz – volume: 49 start-page: 4425 year: 2006 end-page: 4436 ident: CR282 article-title: Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure–activity relationship publication-title: J Med Chem doi: 10.1021/jm0602413 contributor: fullname: Rogers – volume: 9 start-page: 58 year: 2002 end-page: 65 ident: CR13 article-title: Effects of stress and hippocampal NMDA receptor antagonism on recognition memory in rats publication-title: Learn Mem doi: 10.1101/lm.46102 contributor: fullname: Kim – volume: 47 start-page: 962 year: 2000 end-page: 968 ident: CR109 article-title: Differential preservation of cognitive functions in geriatric patients with lifelong chronic schizophrenia: less impairment in reading compared with other skill areas publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(00)00245-6 contributor: fullname: Davis – volume: 480 start-page: 133 year: 2003 end-page: 150 ident: CR268 article-title: The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2003.08.101 contributor: fullname: Di Marzo – volume: 10 start-page: 156 year: 2009 end-page: 162 ident: CR49 article-title: Effect of donepezil added to atypical antipsychotics on cognition in patients with schizophrenia: an open-label trial publication-title: World J Biol Psychiatry doi: 10.1080/15622970701432551 contributor: fullname: Kim – volume: 132 start-page: 303 year: 1997 end-page: 310 ident: CR233 article-title: Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood publication-title: Psychopharmacology (Berl) doi: 10.1007/s002130050349 contributor: fullname: Weinberger – volume: 572 start-page: 151 year: 2007 end-page: 159 ident: CR232 article-title: Cholinergic drugs affect novel object recognition in rats: relation with hippocampal EEG? publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2007.06.018 contributor: fullname: Blokland – volume: 207 start-page: 144 year: 2010 end-page: 150 ident: CR60 article-title: Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses sub-chronic PCP-induced deficits in the novel object recognition task in rats publication-title: Behav Brain Res doi: 10.1016/j.bbr.2009.09.048 contributor: fullname: Plath – volume: 328 start-page: 921 year: 2009 end-page: 930 ident: CR253 article-title: The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.147884 contributor: fullname: Hutson – volume: 170 start-page: 358 year: 2003 end-page: 367 ident: CR285 article-title: Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04–6790 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-003-1552-5 contributor: fullname: Fone – volume: 121 start-page: 815 year: 2007 end-page: 825 ident: CR249 article-title: Enhanced recognition memory following glycine transporter 1 deletion in forebrain neurons publication-title: Behav Neurosci doi: 10.1037/0735-7044.121.5.815 contributor: fullname: Yee – volume: 110 start-page: 577 year: 2003 end-page: 590 ident: CR64 article-title: Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat publication-title: J Neural Transm doi: 10.1007/s00702-003-0812-1 contributor: fullname: Li – volume: 24 start-page: 2894 year: 2006 end-page: 2902 ident: CR24 article-title: Isolation rearing induces recognition memory deficits accompanied by cytoskeletal alterations in rat hippocampus publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2006.05170.x contributor: fullname: Marsden – volume: 13 start-page: 1035 year: 2010 end-page: 1051 ident: CR184 article-title: The dopamine D(3) receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145710000775 contributor: fullname: Schneider – volume: 956 start-page: 349 year: 2002 end-page: 357 ident: CR127 article-title: Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism publication-title: Brain Res doi: 10.1016/S0006-8993(02)03570-9 contributor: fullname: Meltzer – volume: 32 start-page: 17 year: 2007 end-page: 34 ident: CR211 article-title: SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301188 contributor: fullname: Scatton – volume: 18 start-page: 321 year: 1990 end-page: 326 ident: CR192 article-title: Nonrecurring-items nonmatching-to-sample in rats: a new paradigm for testing non-spatial working memory publication-title: Psychobiology contributor: fullname: Wood – volume: 61 start-page: 515 year: 2007 end-page: 522 ident: CR52 article-title: Escalating dose, multiple binge methamphetamine regimen does not impair recognition memory in rats publication-title: Synapse doi: 10.1002/syn.20397 contributor: fullname: Segal – volume: 105 start-page: 20 year: 2001 end-page: 22 ident: CR92 article-title: Linkage disequilibrium for schizophrenia at the chromosome 15q13–14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7) publication-title: Am J Med Genet doi: 10.1002/1096-8628(20010108)105:1<20::AID-AJMG1047>3.0.CO;2-C contributor: fullname: Gejman – volume: 110 start-page: 149 year: 2009 end-page: 155 ident: CR252 article-title: Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder publication-title: Schizophr Res doi: 10.1016/j.schres.2009.02.001 contributor: fullname: Lajtha – volume: 15 start-page: 347 year: 2005 end-page: 355 ident: CR88 article-title: Hippocampal lesions that abolish spatial maze performance spare object recognition memory at delays of up to 48 hours publication-title: Hippocampus doi: 10.1002/hipo.20059 contributor: fullname: Bussey – volume: 1 start-page: 318 year: 1998 end-page: 323 ident: CR114 article-title: Impaired recruitment of the hippocampus during conscious recollection in schizophrenia publication-title: Nat Neurosci doi: 10.1038/1137 contributor: fullname: Alpert – volume: 25 start-page: 949 year: 2003 end-page: 964 ident: CR244 article-title: Organizational and visual memory deficits in schizophrenia and bipolar psychoses using the Rey–Osterrieth complex figure: effects of duration of illness publication-title: J Clin Exp Neuropsychol doi: 10.1076/jcen.25.7.949.16482 contributor: fullname: Tsuang – volume: 97 start-page: 51 year: 2007 end-page: 59 ident: CR42 article-title: Obstetric conditions and risk of first admission with schizophrenia: a Danish national register based study publication-title: Schizophr Res doi: 10.1016/j.schres.2007.07.018 contributor: fullname: Mortensen – volume: 149 start-page: 123 year: 2007 end-page: 130 ident: CR197 article-title: Differential effects of the N-methyl-d-aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice publication-title: Neuroscience doi: 10.1016/j.neuroscience.2007.07.019 contributor: fullname: Carlsson – volume: 336 start-page: 242 year: 2011 end-page: 253 ident: CR272 article-title: RG3487, a novel nicotinic alpha7 receptor partial agonist, improves cognition and sensorimotor gating in rodents publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.110.171892 contributor: fullname: Lowe – volume: 186 start-page: 78 year: 2008 end-page: 83 ident: CR138 article-title: D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats publication-title: Behav Brain Res doi: 10.1016/j.bbr.2007.07.033 contributor: fullname: Chaki – volume: 67 start-page: 172 year: 1997 end-page: 175 ident: CR181 article-title: Object recognition in mice: improvement of memory by glucose publication-title: Neurobiol Learn Mem doi: 10.1006/nlme.1996.3755 contributor: fullname: Messier – volume: 58 start-page: 365 year: 2010 end-page: 373 ident: CR30 article-title: AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2009.10.003 contributor: fullname: Bonhaus – volume: 248 start-page: 183 year: 1998 end-page: 186 ident: CR215 article-title: Intraseptal infusions of a low dose of AP5, a NMDA receptor antagonist, improves memory in an object recognition task in rats publication-title: Neurosci Lett doi: 10.1016/S0304-3940(98)00358-9 contributor: fullname: Bizot – volume: 324 start-page: 587 year: 2008 end-page: 599 ident: CR183 article-title: S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrr ol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.107.126706 contributor: fullname: Lavielle – volume: 64 start-page: 633 year: 2007 end-page: 647 ident: CR139 article-title: Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.64.6.633 contributor: fullname: Lieberman – volume: 983 start-page: 215 year: 2003 end-page: 222 ident: CR213 article-title: The 5-HT 1A receptor antagonist WAY 100635 improves rats performance in different models of amnesia evaluated by the object recognition task publication-title: Brain Res doi: 10.1016/S0006-8993(03)03091-9 contributor: fullname: Muller – volume: 115 start-page: 205 year: 2000 end-page: 218 ident: CR221 article-title: The role of acetylcholine in cortical synaptic plasticity publication-title: Behav Brain Res doi: 10.1016/S0166-4328(00)00259-X contributor: fullname: Rasmusson – volume: 325 start-page: 1212 year: 2002 end-page: 1213 ident: CR11 article-title: Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study publication-title: BMJ doi: 10.1136/bmj.325.7374.1212 contributor: fullname: Moffitt – volume: 190 start-page: 515 year: 2007 end-page: 520 ident: CR17 article-title: Substance use in a population-based clinic sample of people with first-episode psychosis publication-title: Br J Psychiatry doi: 10.1192/bjp.bp.106.024448 contributor: fullname: Jones – volume: 86 start-page: 1100 year: 1974 end-page: 1109 ident: CR97 article-title: Recognition impaired and association intact in the memory of monkeys after transection of the fornix publication-title: J Comp Physiol Psychol doi: 10.1037/h0037649 contributor: fullname: Gaffan – volume: 162 start-page: 1963 year: 2005 end-page: 1966 ident: CR43 article-title: Face recognition memory deficits and visual object memory performance in patients with schizophrenia and their relatives publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.162.10.1963 contributor: fullname: Gur – volume: 14 start-page: 145 year: 2001 end-page: 152 ident: CR174 article-title: Activation of muscarinic receptors induces protein synthesis-dependent long-lasting depression in the perirhinal cortex publication-title: Eur J Neurosci doi: 10.1046/j.0953-816x.2001.01631.x contributor: fullname: Bashir – volume: 83 start-page: 7 year: 1997 end-page: 14 ident: CR234 article-title: Trans-synaptic stimulation of cortical acetylcholine and enhancement of attentional functions: a rational approach for the development of cognition enhancers publication-title: Behav Brain Res doi: 10.1016/S0166-4328(97)86039-1 contributor: fullname: Bruno – volume: 59 start-page: 29 year: 2003 end-page: 33 ident: CR36 article-title: An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia publication-title: Schizophr Res doi: 10.1016/S0920-9964(01)00387-5 contributor: fullname: Gold – volume: 32 start-page: 312 year: 1992 end-page: 333 ident: CR258 article-title: The contribution of constructional accuracy and organizational strategy to nonverbal recall in schizophrenia and chronic alcoholism publication-title: Biol Psychiatry doi: 10.1016/0006-3223(92)90036-Y contributor: fullname: Pfefferbaum – ident: CR284 – volume: 97 start-page: 107 year: 1998 end-page: 113 ident: CR187 article-title: The medial frontal cortex and temporal memory: tests using spontaneous exploratory behaviour in the rat publication-title: Behav Brain Res doi: 10.1016/S0166-4328(98)00032-1 contributor: fullname: Laiacona – volume: 9 start-page: 592 year: 2010 end-page: 602 ident: CR218 article-title: Complexin2 null mutation requires a ‘second hit’ for induction of phenotypic changes relevant to schizophrenia publication-title: Genes Brain Behav contributor: fullname: Ehrenreich – volume: 51 start-page: 349 year: 2002 end-page: 357 ident: CR95 article-title: A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(01)01342-7 contributor: fullname: Davis – volume: 15 start-page: 7150 year: 1995 end-page: 7157 ident: CR117 article-title: Local modulation of hippocampal acetylcholine release by dopamine D1 receptors: a combined receptor autoradiography and in vivo dialysis study publication-title: J Neurosci contributor: fullname: Quirion – volume: 25 start-page: 10831 year: 2005 end-page: 10843 ident: CR74 article-title: Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2999-05.2005 contributor: fullname: Artigas – volume: 38 start-page: 22 year: 1995 end-page: 33 ident: CR91 article-title: Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia publication-title: Biol Psychiatry doi: 10.1016/0006-3223(94)00252-X contributor: fullname: Leonard – volume: 146 start-page: 1719 year: 2007 end-page: 1725 ident: CR212 article-title: Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats publication-title: Neuroscience doi: 10.1016/j.neuroscience.2007.03.018 contributor: fullname: Schröder – volume: 197 start-page: 210 year: 2009 end-page: 218 ident: CR56 article-title: Maternal dietary zinc supplementation prevents aberrant behaviour in an object recognition task in mice offspring exposed to LPS in early pregnancy publication-title: Behav Brain Res doi: 10.1016/j.bbr.2008.08.022 contributor: fullname: Rofe – volume: 27 start-page: 47 year: 2002 end-page: 54 ident: CR163 article-title: Neonatal damage of the ventral hippocampus impairs working memory in the rat publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(02)00282-8 contributor: fullname: Moghaddam – volume: 32 start-page: 1055 year: 2008 end-page: 1070 ident: CR280 article-title: Object recognition memory: neurobiological mechanisms of encoding, consolidation and retrieval publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2008.04.004 contributor: fullname: Bussey – volume: 213 start-page: 413 year: 2011 end-page: 430 ident: CR141 article-title: E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-010-1854-3 contributor: fullname: Fone – volume: 7 start-page: 117 year: 2004 end-page: 123 ident: CR265 article-title: A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145703004024 contributor: fullname: Gogus – volume: 59 start-page: 75 year: 2006 end-page: 84 ident: CR136 article-title: Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.06.006 contributor: fullname: Yamada – volume: 13 start-page: 1343 year: 2010 end-page: 1354 ident: CR199 article-title: Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145710000222 contributor: fullname: Nabeshima – volume: 174 start-page: 334 year: 2004 end-page: 340 ident: CR193 article-title: Nicotine improves delayed recognition in schizophrenic patients publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-003-1764-8 contributor: fullname: Thaker – volume: 148 start-page: 224 year: 1991 end-page: 230 ident: CR76 article-title: Drug abuse in schizophrenic patients: clinical correlates and reasons for use publication-title: Am J Psychiatry contributor: fullname: Frances – ident: CR289 – volume: 9 start-page: 27 year: 2010 ident: CR245 article-title: A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia publication-title: Ann Gen Psychiatr doi: 10.1186/1744-859X-9-27 contributor: fullname: Hashimoto – ident: CR41 – volume: 31 start-page: 47 year: 1988 end-page: 59 ident: CR84 article-title: A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data publication-title: Behav Brain Res doi: 10.1016/0166-4328(88)90157-X contributor: fullname: Delacour – volume: 10 start-page: 2307 year: 1999 end-page: 2311 ident: CR22 article-title: Cellular changes in rat brain areas associated with neonatal hippocampal damage publication-title: Neuroreport doi: 10.1097/00001756-199908020-00016 contributor: fullname: Bogerts – volume: 181 start-page: 358 year: 2005 end-page: 363 ident: CR94 article-title: Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-005-2235-1 contributor: fullname: Goff – volume: 6 start-page: 312 year: 2005 end-page: 324 ident: CR158 article-title: Cortical inhibitory neurons and schizophrenia publication-title: Nat Rev Neurosci doi: 10.1038/nrn1648 contributor: fullname: Volk – volume: 10 start-page: 40 year: 2005 end-page: 68 ident: CR108 article-title: Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence publication-title: Mol Psychiatr doi: 10.1038/sj.mp.4001558 contributor: fullname: Weinberger – volume: 34 start-page: 1322 year: 2009 end-page: 1329 ident: CR161 article-title: A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia publication-title: Neuropsychopharmacology doi: 10.1038/npp.2008.200 contributor: fullname: Gage – volume: 93 start-page: 482 year: 2009 end-page: 490 ident: CR118 article-title: Chronic periadolescent cannabinoid treatment enhances adult hippocampal PSA-NCAM expression in male Wistar rats but only has marginal effects on anxiety, learning and memory publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2009.06.013 contributor: fullname: Ambrosio – volume: 370 start-page: 319 year: 2007 end-page: 328 ident: CR190 article-title: Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review publication-title: Lancet doi: 10.1016/S0140-6736(07)61162-3 contributor: fullname: Lewis – volume: 148 start-page: 1474 year: 1991 end-page: 1486 ident: CR63 article-title: Dopamine in schizophrenia: a review and reconceptualization publication-title: Am J Psychiatry contributor: fullname: Davidson – volume: 321 start-page: 716 year: 2007 end-page: 725 ident: CR26 article-title: The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.106.118976 contributor: fullname: Koenig – volume: 179 start-page: 144 year: 2005 end-page: 150 ident: CR99 article-title: A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-004-2032-2 contributor: fullname: Schoenfeld – volume: 98 start-page: 185 year: 2006 end-page: 205 ident: CR153 article-title: Nicotinic-antipsychotic drug interactions and cognitive function publication-title: EXS contributor: fullname: Rezvani – volume: 30 start-page: 2169 year: 2005 end-page: 2179 ident: CR160 article-title: The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300777 contributor: fullname: Schreiber – volume: 1279 start-page: 189 year: 2009 end-page: 196 ident: CR147 article-title: Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors publication-title: Brain Res doi: 10.1016/j.brainres.2009.05.004 contributor: fullname: Hashimoto – volume: 69 start-page: 536 year: 2007 end-page: 545 ident: CR227 article-title: The neuroprotective effects of caffeine: a prospective population study (the Three City Study) publication-title: Neurology doi: 10.1212/01.wnl.0000266670.35219.0c contributor: fullname: Ancelin – volume: 17 start-page: 277 year: 2007 end-page: 288 ident: CR237 article-title: Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2006.06.009 contributor: fullname: Blokland – volume: 31 start-page: 637 year: 2006 end-page: 643 ident: CR251 article-title: Effects of nicotine nasal spray on cognitive function in schizophrenia publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300881 contributor: fullname: Khan – volume: 97 start-page: 12375 year: 2000 end-page: 12379 ident: CR171 article-title: The visual paired-comparison task as a measure of declarative memory publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.220398097 contributor: fullname: Squire – volume: 63 start-page: 630 year: 2006 end-page: 638 ident: CR200 article-title: Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.63.6.630 contributor: fullname: Freedman – volume: 21 start-page: 333 year: 2011 end-page: 343 ident: CR180 article-title: Activation of alpha7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2010.06.003 contributor: fullname: Neill – volume: 280 start-page: 1117 year: 1997 end-page: 1136 ident: CR8 article-title: Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function publication-title: J Pharmacol Exp Ther contributor: fullname: Maelicke – volume: 19 start-page: 2409 year: 2009 end-page: 2412 ident: CR250 article-title: Synthesis and SAR of tolylamine 5-HT6 antagonists publication-title: Bioorg Med Chem Lett doi: 10.1016/j.bmcl.2009.03.077 contributor: fullname: Schwarz – volume: 20 start-page: 8853 year: 2000 end-page: 8860 ident: CR51 article-title: Impaired recognition memory in rats after damage to the hippocampus publication-title: J Neurosci contributor: fullname: Squire – volume: 214 start-page: 403 year: 2011 end-page: 413 ident: CR61 article-title: Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-010-2039-9 contributor: fullname: Hansen – volume: 35 start-page: 2262 year: 2010 end-page: 2273 ident: CR202 article-title: Chronic adolescent exposure to Delta-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes publication-title: Neuropsychopharmacology doi: 10.1038/npp.2010.100 contributor: fullname: Waddington – volume: 281 start-page: 1349 year: 1998 end-page: 1352 ident: CR189 article-title: Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats publication-title: Science doi: 10.1126/science.281.5381.1349 contributor: fullname: Adams – volume: 194 start-page: 21 year: 2007 end-page: 32 ident: CR194 article-title: Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-007-0820-1 contributor: fullname: Yamada – volume: 10 start-page: 376 year: 2007 end-page: 384 ident: CR271 article-title: Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory publication-title: Nat Neurosci doi: 10.1038/nn1846 contributor: fullname: Arnsten – volume: 20 start-page: 11 year: 1957 end-page: 21 ident: CR241 article-title: Loss of recent memory after bilateral hippocampal lesions publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.20.1.11 contributor: fullname: Milner – volume: 327 start-page: 827 year: 2008 end-page: 839 ident: CR164 article-title: ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.136580 contributor: fullname: Marquis – volume: 32 start-page: 1810 year: 2008 end-page: 1815 ident: CR7 article-title: A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia publication-title: Prog Neuropsychopharmacol Biol Psychiatr doi: 10.1016/j.pnpbp.2008.08.001 contributor: fullname: Rezazadeh – volume: 197 start-page: 435 year: 2009 end-page: 441 ident: CR23 article-title: Behavioral characterization of dysbindin-1 deficient sandy mice publication-title: Behav Brain Res contributor: fullname: Srivastava – volume: 198 start-page: 141 year: 2008 end-page: 148 ident: CR47 article-title: Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1103-1 contributor: fullname: Chen – volume: 161 start-page: 1219 year: 2004 end-page: 1223 ident: CR274 article-title: Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.161.7.1219 contributor: fullname: Davidson – volume: 76 start-page: 135 year: 2005 end-page: 157 ident: CR68 article-title: A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors publication-title: Schizophr Res doi: 10.1016/j.schres.2005.02.010 contributor: fullname: Diaz – volume: 67 start-page: 165 year: 1995 end-page: 199 ident: CR256 article-title: The role of serotonergic–cholinergic interactions in the mediation of cognitive behaviour publication-title: Behav Brain Res doi: 10.1016/0166-4328(94)00157-B contributor: fullname: Sahgal – volume: 62 start-page: 450 year: 2010 end-page: 456 ident: CR44 article-title: Memantine is a useful drug to prevent the spatial and non-spatial memory deficits induced by methamphetamine in rats publication-title: Pharmacol Res doi: 10.1016/j.phrs.2010.05.004 contributor: fullname: Escubedo – volume: 13 start-page: 451 year: 2010 end-page: 460 ident: CR150 article-title: A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145709990939 contributor: fullname: Tsai – volume: 30 start-page: 7236 year: 2010 end-page: 7248 ident: CR48 article-title: Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0736-10.2010 contributor: fullname: Castillo – volume: 202 start-page: 111 year: 2009 end-page: 123 ident: CR143 article-title: Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04–6790, in the Novel Object Discrimination task publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1334-1 contributor: fullname: Fone – volume: 757 start-page: 245 year: 1995 end-page: 252 ident: CR154 article-title: Acute and chronic nicotinic interactions with dopamine systems and working memory performance publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.1995.tb17481.x contributor: fullname: Rose – volume: 36 start-page: 782 year: 2011 end-page: 792 ident: CR222 article-title: Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2010.212 contributor: fullname: See – volume: 49 start-page: 89 year: 2003 end-page: 96 ident: CR238 article-title: Neurotoxic methamphetamine regimen severely impairs recognition memory in rats publication-title: Synapse doi: 10.1002/syn.10210 contributor: fullname: Marshall – volume: 165 start-page: 1040 year: 2008 end-page: 1047 ident: CR93 article-title: Initial phase 2 trial of a nicotinic agonist in schizophrenia publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2008.07071135 contributor: fullname: Kem – volume: 519 start-page: 114 year: 2005 end-page: 117 ident: CR110 article-title: Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2005.07.002 contributor: fullname: Iyo – volume: 192 start-page: 481 year: 1976 end-page: 483 ident: CR58 article-title: Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs publication-title: Science doi: 10.1126/science.3854 contributor: fullname: Snyder – volume: 365 start-page: 441 year: 1993 end-page: 445 ident: CR243 article-title: Dopamine D4 receptors elevated in schizophrenia publication-title: Nature doi: 10.1038/365441a0 contributor: fullname: Van Tol – volume: 26 start-page: 365 year: 2006 end-page: 384 ident: CR55 article-title: Glutamate and schizophrenia: beyond the dopamine hypothesis publication-title: Cell Mol Neurobiol doi: 10.1007/s10571-006-9062-8 contributor: fullname: Coyle – volume: 17 start-page: 79 year: 2006 end-page: 83 ident: CR201 article-title: Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice publication-title: Neuroreport doi: 10.1097/01.wnr.0000192738.31029.0a contributor: fullname: Waddington – volume: 120 start-page: 142 year: 1995 end-page: 149 ident: CR133 article-title: Effect of scopolamine on visual attention in rats publication-title: Psychopharmacology (Berl) doi: 10.1007/BF02246186 contributor: fullname: Higgins – volume: 774 start-page: 167 year: 1997 end-page: 174 ident: CR45 article-title: WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid publication-title: Brain Res doi: 10.1016/S0006-8993(97)81700-3 contributor: fullname: Samanin – volume: 22 start-page: 115 year: 2001 end-page: 126 ident: CR173 article-title: Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia publication-title: J Chem Neuroanat doi: 10.1016/S0891-0618(01)00117-X contributor: fullname: Nordberg – volume: 170 start-page: 800 year: 2010 end-page: 807 ident: CR79 article-title: Cognition in transmembrane domain neuregulin 1 mutant mice publication-title: Neuroscience doi: 10.1016/j.neuroscience.2010.07.042 contributor: fullname: Karl – volume: 80 start-page: 9 year: 1996 end-page: 25 ident: CR85 article-title: Neurotoxic lesions of the perirhinal cortex do not mimic the behavioural effects of fornix transection in the rat publication-title: Behav Brain Res doi: 10.1016/0166-4328(96)00006-X contributor: fullname: Aggleton – volume: 8 start-page: 20 year: 2001 end-page: 25 ident: CR220 article-title: Effects of pharmacologically induced changes in NMDA-receptor activity on long-term memory in humans publication-title: Learn Mem doi: 10.1101/lm.33701 contributor: fullname: Rammsayer – volume: 61 start-page: 774 year: 2004 end-page: 780 ident: CR35 article-title: Serologic evidence of prenatal influenza in the etiology of schizophrenia publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.61.8.774 contributor: fullname: Susser – volume: 33 start-page: 2934 year: 2008 end-page: 2945 ident: CR124 article-title: Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus publication-title: Neuropsychopharmacology doi: 10.1038/npp.2008.20 contributor: fullname: Meltzer – volume: 18 start-page: 117 year: 2008 end-page: 121 ident: CR144 article-title: Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: a preliminary study publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2007.07.008 contributor: fullname: Fischel – volume: 78 start-page: 880 year: 2009 end-page: 888 ident: CR260 article-title: Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2009.07.005 contributor: fullname: Smith – volume: 17 start-page: 616 year: 2007 end-page: 626 ident: CR246 article-title: Subsequent exposure to the choline uptake enhancer MKC-231 antagonizes phencyclidine-induced behavioral deficits and reduction in septal cholinergic neurons in rats publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2007.02.011 contributor: fullname: Kawahara – volume: 20 start-page: 140 year: 1963 end-page: 144 ident: CR46 article-title: Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain publication-title: Acta Pharmacol Toxicol (Copenh) doi: 10.1111/j.1600-0773.1963.tb01730.x contributor: fullname: Lindqvist – volume: 12 start-page: 221 year: 2005 end-page: 223 ident: CR81 article-title: Recollection in an episodic-like memory task in the rat publication-title: Learn Mem doi: 10.1101/lm.92505 contributor: fullname: Zinkivskav – volume: 25 start-page: 662 year: 2001 end-page: 668 ident: CR66 article-title: The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(01)00265-2 contributor: fullname: Li – volume: 18 start-page: 515 year: 2007 end-page: 520 ident: CR16 article-title: WIN-55,212-2 chronically implanted into the CA3 region of the dorsal hippocampus impairs learning: a novel method for studying chronic, brain-area-specific effects of cannabinoids publication-title: Behav Pharmacol doi: 10.1097/FBP.0b013e3282d9e9f9 contributor: fullname: Haller – volume: 25 start-page: 792 year: 2010 end-page: 800 ident: CR255 article-title: PD168077, a D4 receptor agonist, reverses object recognition deficits in rats: potential role for D4 receptor mechanisms in improving cognitive dysfunction in schizophrenia publication-title: J Psychopharmacol doi: 10.1177/0269881110387840 contributor: fullname: Young – volume: 27 start-page: 2548 year: 2007 end-page: 2559 ident: CR18 article-title: Perceptual functions of perirhinal cortex in rats: zero-delay object recognition and simultaneous oddity discriminations publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5171-06.2007 contributor: fullname: Bussey – volume: 32 start-page: 200 year: 2006 end-page: 202 ident: CR32 article-title: Prenatal infection as a risk factor for schizophrenia publication-title: Schizophr Bull doi: 10.1093/schbul/sbj052 contributor: fullname: Brown – volume: 85 start-page: 253 year: 2006 end-page: 260 ident: CR67 article-title: Beneficial effects of galantamine on performance in the object recognition task in Swiss mice: deficits induced by scopolamine and by prolonging the retention interval publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2006.08.007 contributor: fullname: Pouzet – volume: 37 start-page: 416 year: 2011 end-page: 425 ident: CR121 article-title: Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia publication-title: Schizophr Bull doi: 10.1093/schbul/sbp089 contributor: fullname: Stein – volume: 338 start-page: R3 year: 1997 end-page: R5 ident: CR229 article-title: Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(97)81951-6 contributor: fullname: Zorn – volume: 153 start-page: 273 year: 2004 end-page: 285 ident: CR106 article-title: Medial prefrontal cortex is involved in spatial temporal order memory but not spatial recognition memory in tests relying on spontaneous exploration in rats publication-title: Behav Brain Res doi: 10.1016/j.bbr.2003.12.004 contributor: fullname: Phillips – volume: 205 start-page: 355 year: 2009 end-page: 359 ident: CR131 article-title: Neonatal lipopolysaccharide induces pathological changes in parvalbumin immunoreactivity in the hippocampus of the rat publication-title: Behav Brain Res doi: 10.1016/j.bbr.2009.07.014 contributor: fullname: Reynolds – volume: 48 start-page: 651 year: 2000 end-page: 657 ident: CR115 article-title: Abnormalities in the thalamus and prefrontal cortex during episodic object recognition in schizophrenia publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(00)00919-7 contributor: fullname: Schacter – volume: 596 start-page: 89 year: 2008 end-page: 97 ident: CR159 article-title: Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one (AC260584) and N-desmethylclozapine publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2008.08.009 contributor: fullname: Meltzer – volume: 22 start-page: 63 year: 2007 end-page: 68 ident: CR151 article-title: A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia publication-title: Int Clin Psychopharmacol doi: 10.1097/YIC.0b013e3280117feb contributor: fullname: Kim – volume: 33 start-page: 2364 year: 2008 end-page: 2372 ident: CR77 article-title: 5-HT6/7 receptor antagonists facilitate dopamine release in the cochlea via a GABAergic disinhibitory mechanism publication-title: Neurochem Res doi: 10.1007/s11064-008-9796-4 contributor: fullname: Zelles – volume: 53 start-page: 2521 year: 2010 end-page: 2527 ident: CR113 article-title: 5-Cyclic amine-3-arylsulfonylindazoles as novel 5-HT6 receptor antagonists publication-title: J Med Chem doi: 10.1021/jm901674f contributor: fullname: Robichaud – volume: 34 start-page: 5 year: 2010 end-page: 9 ident: CR29 article-title: The nitric oxide-releasing derivative of ferulic acid NCX 2057 antagonized delay-dependent and scopolamine-induced performance deficits in a recognition memory task in the rat publication-title: Prog Neuropsychopharmacol Biol Psychiatr doi: 10.1016/j.pnpbp.2009.09.001 contributor: fullname: Pitsikas – volume: 15 start-page: 730 year: 2005 end-page: 737 ident: CR38 article-title: Object memory and perception in the medial temporal lobe: an alternative approach publication-title: Curr Opin Neurobiol doi: 10.1016/j.conb.2005.10.014 contributor: fullname: Saksida – volume: 25 start-page: 4243 year: 2005 end-page: 4251 ident: CR276 article-title: Glutamate receptors in perirhinal cortex mediate encoding, retrieval, and consolidation of object recognition memory publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0480-05.2005 contributor: fullname: Bussey – volume: 1218 start-page: 257 year: 2008 end-page: 266 ident: CR210 article-title: Early enriched housing results in partial recovery of memory deficits in female, but not in male, rats after neonatal hypoxia–ischemia publication-title: Brain Res doi: 10.1016/j.brainres.2008.04.010 contributor: fullname: Netto – volume: 12 start-page: 232 year: 2007 ident: 2536_CR219 publication-title: Mol Psychiatr doi: 10.1038/sj.mp.4001924 contributor: fullname: TJ Raedler – volume: 93 start-page: 221 year: 2010 ident: 2536_CR281 publication-title: Neurobiol Learn Mem doi: 10.1016/j.nlm.2009.10.002 contributor: fullname: BD Winters – volume: 26 start-page: 9520 year: 2006 ident: 2536_CR279 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2319-06.2006 contributor: fullname: BD Winters – volume: 206 start-page: 32 year: 2010 ident: 2536_CR126 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2009.08.027 contributor: fullname: D Ibi – volume: 9 start-page: 27 year: 2010 ident: 2536_CR245 publication-title: Ann Gen Psychiatr doi: 10.1186/1744-859X-9-27 contributor: fullname: A Shiina – volume: 47 start-page: 962 year: 2000 ident: 2536_CR109 publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(00)00245-6 contributor: fullname: PD Harvey – volume: 161 start-page: 1219 year: 2004 ident: 2536_CR274 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.161.7.1219 contributor: fullname: M Weiser – volume: 26 start-page: 365 year: 2006 ident: 2536_CR55 publication-title: Cell Mol Neurobiol doi: 10.1007/s10571-006-9062-8 contributor: fullname: JT Coyle – volume: 148 start-page: 1474 year: 1991 ident: 2536_CR63 publication-title: Am J Psychiatry doi: 10.1176/ajp.148.11.1474 contributor: fullname: KL Davis – volume: 13 start-page: 9 year: 1995 ident: 2536_CR148 publication-title: Neuropsychopharmacology doi: 10.1016/0893-133X(94)00131-I contributor: fullname: AC Lahti – volume: 22 start-page: 115 year: 2001 ident: 2536_CR173 publication-title: J Chem Neuroanat doi: 10.1016/S0891-0618(01)00117-X contributor: fullname: A Marutle – volume: 18 start-page: 321 year: 1990 ident: 2536_CR192 publication-title: Psychobiology doi: 10.3758/BF03327250 contributor: fullname: DG Mumby – volume: 26 start-page: 583 year: 2002 ident: 2536_CR247 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(01)00400-6 contributor: fullname: S Shirazi-Southall – volume: 154 start-page: 1013 year: 1997 ident: 2536_CR283 publication-title: Am J Psychiatry doi: 10.1176/ajp.154.7.1013 contributor: fullname: TU Woo – ident: 2536_CR289 – volume: 115 start-page: 367 issue: Pt 2 year: 1992 ident: 2536_CR96 publication-title: Brain doi: 10.1093/brain/115.2.367 contributor: fullname: KJ Friston – volume: 205 start-page: 355 year: 2009 ident: 2536_CR131 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2009.07.014 contributor: fullname: TA Jenkins – volume: 10 start-page: 147 year: 2009 ident: 2536_CR166 publication-title: BMC Med Genet doi: 10.1186/1471-2350-10-147 contributor: fullname: FW Lung – volume: 9 start-page: 377 year: 2002 ident: 2536_CR169 publication-title: Eur J Neurol doi: 10.1046/j.1468-1331.2002.00421.x contributor: fullname: L Maia – volume: 32 start-page: 312 year: 1992 ident: 2536_CR258 publication-title: Biol Psychiatry doi: 10.1016/0006-3223(92)90036-Y contributor: fullname: EV Sullivan – volume: 138 start-page: 217 year: 1998 ident: 2536_CR155 publication-title: Psychopharmacology (Berl) doi: 10.1007/s002130050667 contributor: fullname: ED Levin – volume: 60 start-page: 645 year: 2006 ident: 2536_CR149 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.04.005 contributor: fullname: HY Lane – volume: 25 start-page: 949 year: 2003 ident: 2536_CR244 publication-title: J Clin Exp Neuropsychol doi: 10.1076/jcen.25.7.949.16482 contributor: fullname: LJ Seidman – volume: 97 start-page: 12375 year: 2000 ident: 2536_CR171 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.220398097 contributor: fullname: JR Manns – volume: 63 start-page: 182 year: 2011 ident: 2536_CR19 publication-title: Pharmacol Rev doi: 10.1124/pr.110.002642 contributor: fullname: JM Beaulieu – volume: 35 start-page: 1059 year: 2009 ident: 2536_CR130 publication-title: Schizophr Bull doi: 10.1093/schbul/sbp110 contributor: fullname: DC Javitt – volume: 13 start-page: 451 year: 2010 ident: 2536_CR150 publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145709990939 contributor: fullname: HY Lane – volume: 248 start-page: 183 year: 1998 ident: 2536_CR215 publication-title: Neurosci Lett doi: 10.1016/S0304-3940(98)00358-9 contributor: fullname: C Puma – volume: 10 start-page: 40 year: 2005 ident: 2536_CR108 publication-title: Mol Psychiatr doi: 10.1038/sj.mp.4001558 contributor: fullname: PJ Harrison – volume: 59 start-page: 75 year: 2006 ident: 2536_CR136 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.06.006 contributor: fullname: H Kamei – volume: 32 start-page: 1055 year: 2008 ident: 2536_CR280 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2008.04.004 contributor: fullname: BD Winters – volume: 17 start-page: 275 year: 2007 ident: 2536_CR240 publication-title: Neuropsychol Rev doi: 10.1007/s11065-007-9031-0 contributor: fullname: JC Scott – volume: 50 start-page: 873 year: 2001 ident: 2536_CR137 publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(01)01251-3 contributor: fullname: S Kapur – volume: 24 start-page: 1299 year: 2006 ident: 2536_CR172 publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2006.05003.x contributor: fullname: B Marcos – volume: 50 start-page: 897 year: 2006 ident: 2536_CR235 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2006.02.005 contributor: fullname: L Schiapparelli – volume: 55 start-page: 149 year: 1998 ident: 2536_CR34 publication-title: Prog Neurobiol doi: 10.1016/S0301-0082(98)00002-1 contributor: fullname: MW Brown – ident: 2536_CR284 – volume: 16 start-page: 446 year: 1988 ident: 2536_CR98 publication-title: Mem Cognit doi: 10.3758/BF03214225 contributor: fullname: JM Gardiner – volume: 56 start-page: 931 year: 2004 ident: 2536_CR170 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2004.09.013 contributor: fullname: D Malaspina – volume: 17 start-page: 277 year: 2007 ident: 2536_CR237 publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2006.06.009 contributor: fullname: R Schreiber – volume: 97 start-page: 51 year: 2007 ident: 2536_CR42 publication-title: Schizophr Res doi: 10.1016/j.schres.2007.07.018 contributor: fullname: M Byrne – volume: 1 start-page: 318 year: 1998 ident: 2536_CR114 publication-title: Nat Neurosci doi: 10.1038/1137 contributor: fullname: S Heckers – volume: 115 start-page: 205 year: 2000 ident: 2536_CR221 publication-title: Behav Brain Res doi: 10.1016/S0166-4328(00)00259-X contributor: fullname: DD Rasmusson – volume: 321 start-page: 716 year: 2007 ident: 2536_CR26 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.106.118976 contributor: fullname: FG Boess – volume: 64 start-page: 51 year: 2001 ident: 2536_CR214 publication-title: Prog Neurobiol doi: 10.1016/S0301-0082(00)00044-7 contributor: fullname: H Prast – volume: 155 start-page: 1021 year: 2008 ident: 2536_CR12 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2008.07.006 contributor: fullname: D Babovic – volume: 149 start-page: 192 year: 2007 ident: 2536_CR14 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2007.07.043 contributor: fullname: SJ Ballaz – volume: 956 start-page: 349 year: 2002 ident: 2536_CR127 publication-title: Brain Res doi: 10.1016/S0006-8993(02)03570-9 contributor: fullname: J Ichikawa – volume: 144 start-page: 1 year: 2007 ident: 2536_CR122 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2006.09.041 contributor: fullname: SE Hori – volume: 224 start-page: 223 year: 2011 ident: 2536_CR261 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2011.05.008 contributor: fullname: SB Taylor – volume: 1294 start-page: 116 year: 2009 ident: 2536_CR83 publication-title: Brain Res doi: 10.1016/j.brainres.2009.07.065 contributor: fullname: RS Ehrlichman – volume: 17 start-page: 79 year: 2006 ident: 2536_CR201 publication-title: Neuroreport doi: 10.1097/01.wnr.0000192738.31029.0a contributor: fullname: CM O’Tuathaigh – volume: 24 start-page: 2013 year: 2004 ident: 2536_CR196 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3763-03.2004 contributor: fullname: S Nemanic – volume: 983 start-page: 215 year: 2003 ident: 2536_CR213 publication-title: Brain Res doi: 10.1016/S0006-8993(03)03091-9 contributor: fullname: N Pitsikas – volume: 757 start-page: 245 year: 1995 ident: 2536_CR154 publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.1995.tb17481.x contributor: fullname: ED Levin – volume: 356 start-page: 191 year: 2004 ident: 2536_CR1 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2003.11.049 contributor: fullname: H Abe – volume: 98 start-page: 185 year: 2006 ident: 2536_CR153 publication-title: EXS contributor: fullname: ED Levin – volume: 194 start-page: 21 year: 2007 ident: 2536_CR194 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-007-0820-1 contributor: fullname: T Nagai – volume: 198 start-page: 141 year: 2008 ident: 2536_CR47 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1103-1 contributor: fullname: MH Chan – volume: 325 start-page: 134 year: 2008 ident: 2536_CR120 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.107.133082 contributor: fullname: WD Hirst – volume: 213 start-page: 413 year: 2011 ident: 2536_CR141 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-010-1854-3 contributor: fullname: I Kendall – volume: 108 start-page: 320 year: 2005 ident: 2536_CR188 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2005.05.001 contributor: fullname: ES Mitchell – volume: 67 start-page: 172 year: 1997 ident: 2536_CR181 publication-title: Neurobiol Learn Mem doi: 10.1006/nlme.1996.3755 contributor: fullname: C Messier – volume: 480 start-page: 133 year: 2003 ident: 2536_CR268 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2003.08.101 contributor: fullname: M Stelt van der – volume: 33 start-page: 1217 year: 2008 ident: 2536_CR140 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301499 contributor: fullname: RS Keefe – volume: 164 start-page: 692 year: 2009 ident: 2536_CR275 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2009.07.061 contributor: fullname: PJ West – volume: 15 start-page: 7150 year: 1995 ident: 2536_CR117 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.15-11-07150.1995 contributor: fullname: AI Hersi – volume: 19 start-page: 495 year: 1999 ident: 2536_CR39 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.19-01-00495.1999 contributor: fullname: TJ Bussey – volume: 25 start-page: 4243 year: 2005 ident: 2536_CR276 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0480-05.2005 contributor: fullname: BD Winters – volume: 774 start-page: 167 year: 1997 ident: 2536_CR45 publication-title: Brain Res doi: 10.1016/S0006-8993(97)81700-3 contributor: fullname: M Carli – volume: 102 start-page: 88 year: 2008 ident: 2536_CR80 publication-title: Schizophr Res doi: 10.1016/j.schres.2007.12.491 contributor: fullname: MA Dyer – volume: 15 start-page: 9 year: 2004 ident: 2536_CR123 publication-title: Neuroreport doi: 10.1097/00001756-200401190-00003 contributor: fullname: JH Hu – volume: 69 start-page: 536 year: 2007 ident: 2536_CR227 publication-title: Neurology doi: 10.1212/01.wnl.0000266670.35219.0c contributor: fullname: K Ritchie – volume: 15 start-page: 347 year: 2005 ident: 2536_CR88 publication-title: Hippocampus doi: 10.1002/hipo.20059 contributor: fullname: SE Forwood – volume: 22 start-page: 63 year: 2007 ident: 2536_CR151 publication-title: Int Clin Psychopharmacol doi: 10.1097/YIC.0b013e3280117feb contributor: fullname: SW Lee – volume: 10 start-page: 210 year: 2010 ident: 2536_CR72 publication-title: Genes Brain Behav doi: 10.1111/j.1601-183X.2010.00656.x contributor: fullname: LM Devito – volume: 32 start-page: 200 year: 2006 ident: 2536_CR32 publication-title: Schizophr Bull doi: 10.1093/schbul/sbj052 contributor: fullname: AS Brown – volume: 186 start-page: 78 year: 2008 ident: 2536_CR138 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2007.07.033 contributor: fullname: J Karasawa – volume: 21 start-page: 2263 year: 2005 ident: 2536_CR277 publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2005.04055.x contributor: fullname: BD Winters – volume: 7 start-page: 117 year: 2004 ident: 2536_CR265 publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145703004024 contributor: fullname: O Tugal – volume: 199 start-page: 637 year: 2008 ident: 2536_CR116 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1183-y contributor: fullname: NR Herring – volume: 162 start-page: 1963 year: 2005 ident: 2536_CR43 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.162.10.1963 contributor: fullname: ME Calkins – volume: 13 start-page: 1102 year: 2007 ident: 2536_CR208 publication-title: Nat Med doi: 10.1038/nm1632 contributor: fullname: ST Patil – volume: 13 start-page: 178 year: 2006 ident: 2536_CR15 publication-title: Learn Mem doi: 10.1101/lm.77806 contributor: fullname: GR Barker – volume: 572 start-page: 151 year: 2007 ident: 2536_CR232 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2007.06.018 contributor: fullname: A Sambeth – volume: 74 start-page: 233 year: 2005 ident: 2536_CR209 publication-title: Schizophr Res doi: 10.1016/j.schres.2004.08.017 contributor: fullname: M Pelletier – volume: 67 start-page: e12 year: 2006 ident: 2536_CR102 publication-title: J Clin Psychiatr doi: 10.4088/JCP.1006e12 contributor: fullname: MF Green – volume: 10 start-page: 455 year: 2006 ident: 2536_CR3 publication-title: Trends Cogn Sci doi: 10.1016/j.tics.2006.08.003 contributor: fullname: JP Aggleton – volume: 165 start-page: 82 year: 2008 ident: 2536_CR37 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2007.07050724 contributor: fullname: RW Buchanan – volume: 38 start-page: 22 year: 1995 ident: 2536_CR91 publication-title: Biol Psychiatry doi: 10.1016/0006-3223(94)00252-X contributor: fullname: R Freedman – volume: 11 start-page: 569 year: 2001 ident: 2536_CR103 publication-title: Hippocampus doi: 10.1002/hipo.1072 contributor: fullname: R Greene – ident: 2536_CR73 doi: 10.1016/j.nbd.2009.04.003 – volume: 34 start-page: 1322 year: 2009 ident: 2536_CR161 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2008.200 contributor: fullname: JA Lieberman – volume: 324 start-page: 587 year: 2008 ident: 2536_CR183 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.107.126706 contributor: fullname: MJ Millan – volume: 83 start-page: 7 year: 1997 ident: 2536_CR234 publication-title: Behav Brain Res doi: 10.1016/S0166-4328(97)86039-1 contributor: fullname: M Sarter – volume: 33 start-page: 1113 year: 2008 ident: 2536_CR216 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301475 contributor: fullname: HR Quinn – volume: 18 start-page: 515 year: 2007 ident: 2536_CR16 publication-title: Behav Pharmacol doi: 10.1097/FBP.0b013e3282d9e9f9 contributor: fullname: I Barna – ident: 2536_CR23 doi: 10.1016/j.bbr.2008.10.011 – volume: 115 start-page: 1169 year: 1995 ident: 2536_CR75 publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.1995.tb15020.x contributor: fullname: SN Dijk – volume: 32 start-page: 17 year: 2007 ident: 2536_CR211 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301188 contributor: fullname: P Pichat – volume: 101 start-page: 587 year: 1987 ident: 2536_CR231 publication-title: Behav Neurosci doi: 10.1037/0735-7044.101.4.587 contributor: fullname: LA Rothblat – volume: 12 start-page: 78 year: 1996 ident: 2536_CR82 publication-title: Nat Genet doi: 10.1038/ng0196-78 contributor: fullname: RP Ebstein – volume: 19 start-page: 2409 year: 2009 ident: 2536_CR250 publication-title: Bioorg Med Chem Lett doi: 10.1016/j.bmcl.2009.03.077 contributor: fullname: JM Singer – volume: 121 start-page: 815 year: 2007 ident: 2536_CR249 publication-title: Behav Neurosci doi: 10.1037/0735-7044.121.5.815 contributor: fullname: P Singer – volume: 110 start-page: 577 year: 2003 ident: 2536_CR64 publication-title: J Neural Transm doi: 10.1007/s00702-003-0812-1 contributor: fullname: LA Dawson – volume: 32 start-page: 78 year: 2007 ident: 2536_CR176 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301098 contributor: fullname: AC McCreary – volume: 52 start-page: 693 year: 2007 ident: 2536_CR62 publication-title: Can J Psychiatr doi: 10.1177/070674370705201103 contributor: fullname: JM Danion – ident: 2536_CR142 doi: 10.1016/j.neuropharm.2004.03.012 – volume: 202 start-page: 1 year: 2010 ident: 2536_CR191 publication-title: Exp Brain Res doi: 10.1007/s00221-009-2103-z contributor: fullname: P Morales – volume: 185 start-page: 595 year: 2008 ident: 2536_CR248 publication-title: Exp Brain Res doi: 10.1007/s00221-007-1186-7 contributor: fullname: N Simola – volume: 19 start-page: 765 year: 2008 ident: 2536_CR286 publication-title: Behav Pharmacol doi: 10.1097/FBP.0b013e32831c3b06 contributor: fullname: ML Woolley – volume: 29 start-page: 1378 year: 2004 ident: 2536_CR107 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300450 contributor: fullname: JG Harris – volume: 9 start-page: 58 year: 2002 ident: 2536_CR13 publication-title: Learn Mem doi: 10.1101/lm.46102 contributor: fullname: KB Baker – volume: 59 start-page: 546 year: 2006 ident: 2536_CR205 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.07.031 contributor: fullname: K Ozawa – volume: 519 start-page: 114 year: 2005 ident: 2536_CR110 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2005.07.002 contributor: fullname: K Hashimoto – volume: 33 start-page: 2934 year: 2008 ident: 2536_CR124 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2008.20 contributor: fullname: M Huang – volume: 325 start-page: 1212 year: 2002 ident: 2536_CR11 publication-title: BMJ doi: 10.1136/bmj.325.7374.1212 contributor: fullname: L Arseneault – volume: 26 start-page: 12186 year: 2006 ident: 2536_CR54 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2818-06.2006 contributor: fullname: RA Cowell – volume: 13 start-page: 1021 year: 2010 ident: 2536_CR10 publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145710000659 contributor: fullname: J Arnt – volume: 156 start-page: 1646 year: 1999 ident: 2536_CR2 publication-title: Am J Psychiatry doi: 10.1176/ajp.156.10.1646 contributor: fullname: CM Adler – volume: 27 start-page: 1056 year: 2002 ident: 2536_CR70 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(02)00372-X contributor: fullname: L Depatie – ident: 2536_CR204 doi: 10.1017/S0033291706008221 – volume: 280 start-page: 1117 year: 1997 ident: 2536_CR8 publication-title: J Pharmacol Exp Ther contributor: fullname: EX Albuquerque – volume: 105 start-page: 7 year: 2001 ident: 2536_CR50 publication-title: Neuroscience doi: 10.1016/S0306-4522(01)00171-3 contributor: fullname: B Clancy – volume: 122 start-page: 158 year: 1995 ident: 2536_CR223 publication-title: Psychopharmacology (Berl) doi: 10.1007/BF02246090 contributor: fullname: W Riedel – volume: 31 start-page: 954 year: 2005 ident: 2536_CR31 publication-title: Schizophr Bull doi: 10.1093/schbul/sbi059 contributor: fullname: E Bromley – volume: 49 start-page: 89 year: 2003 ident: 2536_CR238 publication-title: Synapse doi: 10.1002/syn.10210 contributor: fullname: N Schroder – volume: 57 start-page: 531 year: 2009 ident: 2536_CR267 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2009.07.022 contributor: fullname: JM Uslaner – volume: 111 start-page: 187 year: 2000 ident: 2536_CR40 publication-title: Behav Brain Res doi: 10.1016/S0166-4328(00)00155-8 contributor: fullname: TJ Bussey – volume: 553 start-page: 109 year: 2006 ident: 2536_CR119 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2006.09.049 contributor: fullname: WD Hirst – volume: 156 start-page: 139 year: 2005 ident: 2536_CR69 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2004.05.016 contributor: fullname: MN Lima de – volume: 181 start-page: 358 year: 2005 ident: 2536_CR94 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-005-2235-1 contributor: fullname: O Freudenreich – volume: 35 start-page: S35 issue: Suppl year: 1999 ident: 2536_CR146 publication-title: Schizophr Res doi: 10.1016/S0920-9964(98)00162-5 contributor: fullname: JH Krystal – volume: 1218 start-page: 257 year: 2008 ident: 2536_CR210 publication-title: Brain Res doi: 10.1016/j.brainres.2008.04.010 contributor: fullname: LO Pereira – volume: 188 start-page: 1217 year: 1975 ident: 2536_CR242 publication-title: Science doi: 10.1126/science.1145194 contributor: fullname: P Seeman – volume: 81 start-page: 308 year: 1998 ident: 2536_CR152 publication-title: Am J Med Genet doi: 10.1002/(SICI)1096-8628(19980710)81:4<308::AID-AJMG6>3.0.CO;2-P contributor: fullname: S Leonard – volume: 12 start-page: 599 year: 2009 ident: 2536_CR270 publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145708009371 contributor: fullname: D Vigano – volume: 100 start-page: 6186 year: 2003 ident: 2536_CR175 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0931309100 contributor: fullname: VS Mattay – volume: 197 start-page: 210 year: 2009 ident: 2536_CR56 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2008.08.022 contributor: fullname: P Coyle – volume: 51 start-page: 349 year: 2002 ident: 2536_CR95 publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(01)01342-7 contributor: fullname: JI Friedman – volume: 6 start-page: 312 year: 2005 ident: 2536_CR158 publication-title: Nat Rev Neurosci doi: 10.1038/nrn1648 contributor: fullname: DA Lewis – volume: 115 start-page: 819 year: 2002 ident: 2536_CR291 publication-title: Chin Med J (Engl) contributor: fullname: Z Zhang – volume: 21 start-page: 333 year: 2011 ident: 2536_CR180 publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2010.06.003 contributor: fullname: SL McLean – volume: 2 start-page: 1483 year: 1987 ident: 2536_CR9 publication-title: Lancet doi: 10.1016/S0140-6736(87)92620-1 contributor: fullname: S Andreasson – volume: 29 start-page: 871 year: 2009 ident: 2536_CR269 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4111-08.2009 contributor: fullname: CJ Dort Van – volume: 63 start-page: 92 year: 2008 ident: 2536_CR111 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2007.04.034 contributor: fullname: K Hashimoto – volume: 146 start-page: 1719 year: 2007 ident: 2536_CR212 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2007.03.018 contributor: fullname: C Pietá Dias – volume: 31 start-page: 673 year: 2007 ident: 2536_CR71 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2007.01.005 contributor: fullname: E Dere – volume: 80 start-page: 9 year: 1996 ident: 2536_CR85 publication-title: Behav Brain Res doi: 10.1016/0166-4328(96)00006-X contributor: fullname: A Ennaceur – volume: 26 start-page: 345 year: 1993 ident: 2536_CR203 publication-title: Dev Psychobiol doi: 10.1002/dev.420260605 contributor: fullname: WH Overman – volume: 25 start-page: 662 year: 2001 ident: 2536_CR66 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(01)00265-2 contributor: fullname: LA Dawson – volume: 27 start-page: 47 year: 2002 ident: 2536_CR163 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(02)00282-8 contributor: fullname: BK Lipska – volume: 76 start-page: 135 year: 2005 ident: 2536_CR68 publication-title: Schizophr Res doi: 10.1016/j.schres.2005.02.010 contributor: fullname: J Leon de – volume: 149 start-page: 123 year: 2007 ident: 2536_CR197 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2007.07.019 contributor: fullname: M Nilsson – volume: 192 start-page: 481 year: 1976 ident: 2536_CR58 publication-title: Science doi: 10.1126/science.3854 contributor: fullname: I Creese – volume: 25 start-page: 10831 year: 2005 ident: 2536_CR74 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2999-05.2005 contributor: fullname: L Diaz-Mataix – volume: 78 start-page: 803 year: 2009 ident: 2536_CR112 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2009.05.030 contributor: fullname: TA Hauser – volume: 179 start-page: 403 year: 2001 ident: 2536_CR59 publication-title: Br J Psychiatry doi: 10.1192/bjp.179.5.403 contributor: fullname: C Dalman – volume: 19 start-page: 397 year: 1993 ident: 2536_CR177 publication-title: J Exp Psychol Learn Mem Cogn doi: 10.1037/0278-7393.19.2.397 contributor: fullname: RD McKee – volume: 8 start-page: 20 year: 2001 ident: 2536_CR220 publication-title: Learn Mem doi: 10.1101/lm.33701 contributor: fullname: TH Rammsayer – volume: 43 start-page: 279 year: 1997 ident: 2536_CR5 publication-title: Brain Res Bull doi: 10.1016/S0361-9230(97)00007-5 contributor: fullname: JP Aggleton – volume: 25 start-page: 792 year: 2010 ident: 2536_CR255 publication-title: J Psychopharmacol doi: 10.1177/0269881110387840 contributor: fullname: P Sood – volume: 64 start-page: 633 year: 2007 ident: 2536_CR139 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.64.6.633 contributor: fullname: RS Keefe – volume: 13 start-page: 1035 year: 2010 ident: 2536_CR184 publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145710000775 contributor: fullname: MJ Millan – volume: 96 start-page: 196 year: 2000 ident: 2536_CR225 publication-title: Am J Med Genet doi: 10.1002/(SICI)1096-8628(20000403)96:2<196::AID-AJMG15>3.0.CO;2-4 contributor: fullname: BP Riley – volume: 38 start-page: 987 year: 2003 ident: 2536_CR273 publication-title: Neuron doi: 10.1016/S0896-6273(03)00358-1 contributor: fullname: EC Warburton – volume: 30 start-page: 2169 year: 2005 ident: 2536_CR160 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300777 contributor: fullname: CK Lieben – volume: 170 start-page: 358 year: 2003 ident: 2536_CR285 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-003-1552-5 contributor: fullname: ML Woolley – volume: 184 start-page: 31 year: 2007 ident: 2536_CR101 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2007.06.012 contributor: fullname: B Grayson – volume: 60 start-page: 530 year: 2006 ident: 2536_CR239 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.04.006 contributor: fullname: MH Schubert – volume: 30 start-page: 3 year: 2007 ident: 2536_CR87 publication-title: Clin Neuropharmacol doi: 10.1097/01.WNF.0000240940.67241.F6 contributor: fullname: B Fagerlund – volume: 20 start-page: 8853 year: 2000 ident: 2536_CR51 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.20-23-08853.2000 contributor: fullname: RE Clark – volume: 51 start-page: 199 year: 1994 ident: 2536_CR145 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1994.03950030035004 contributor: fullname: JH Krystal – volume: 44 start-page: 1081 year: 1998 ident: 2536_CR264 publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(98)00279-0 contributor: fullname: G Tsai – volume: 42 start-page: 1293 year: 2004 ident: 2536_CR207 publication-title: Neuropsychologia doi: 10.1016/j.neuropsychologia.2004.03.005 contributor: fullname: O Pascalis – volume: 17 start-page: 616 year: 2007 ident: 2536_CR246 publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2007.02.011 contributor: fullname: Y Shirayama – volume: 14 start-page: 459 year: 2011 ident: 2536_CR198 publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145710001239 contributor: fullname: M Niwa – volume: 202 start-page: 315 year: 2009 ident: 2536_CR195 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1240-6 contributor: fullname: T Nagai – volume: 27 start-page: 2548 year: 2007 ident: 2536_CR18 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5171-06.2007 contributor: fullname: SJ Bartko – volume: 19 start-page: 133 year: 1986 ident: 2536_CR4 publication-title: Behav Brain Res doi: 10.1016/0166-4328(86)90011-2 contributor: fullname: JP Aggleton – volume: 207 start-page: 144 year: 2010 ident: 2536_CR60 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2009.09.048 contributor: fullname: T Damgaard – volume: 18 start-page: 7075 year: 1998 ident: 2536_CR217 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.18-18-07075.1998 contributor: fullname: KA Radcliffe – volume: 19 start-page: 143 year: 1994 ident: 2536_CR157 publication-title: Psychoneuroendocrinology doi: 10.1016/0306-4530(94)90004-3 contributor: fullname: S Levine – volume: 179 start-page: 144 year: 2005 ident: 2536_CR99 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-004-2032-2 contributor: fullname: DC Goff – volume: 53 start-page: 2521 year: 2010 ident: 2536_CR113 publication-title: J Med Chem doi: 10.1021/jm901674f contributor: fullname: SN Haydar – volume: 161 start-page: 116 year: 2004 ident: 2536_CR185 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.161.1.116 contributor: fullname: MJ Minzenberg – volume: 33 start-page: 1453 year: 2008 ident: 2536_CR20 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301510 contributor: fullname: AM Belcher – volume: 10 start-page: 376 year: 2007 ident: 2536_CR271 publication-title: Nat Neurosci doi: 10.1038/nn1846 contributor: fullname: S Vijayraghavan – volume: 49 start-page: 4425 year: 2006 ident: 2536_CR282 publication-title: J Med Chem doi: 10.1021/jm0602413 contributor: fullname: DG Wishka – volume: 105 start-page: 20 year: 2001 ident: 2536_CR92 publication-title: Am J Med Genet doi: 10.1002/1096-8628(20010108)105:1<20::AID-AJMG1047>3.0.CO;2-C contributor: fullname: R Freedman – volume: 20 start-page: 140 year: 1963 ident: 2536_CR46 publication-title: Acta Pharmacol Toxicol (Copenh) doi: 10.1111/j.1600-0773.1963.tb01730.x contributor: fullname: A Carlsson – volume: 63 start-page: 630 year: 2006 ident: 2536_CR200 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.63.6.630 contributor: fullname: A Olincy – volume: 59 start-page: 1011 year: 2002 ident: 2536_CR78 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.59.11.1011 contributor: fullname: GM Doniger – volume: 7 start-page: 105 year: 2001 ident: 2536_CR226 publication-title: Neurocase doi: 10.1093/neucas/7.2.105 contributor: fullname: SC Risch – volume: 104 start-page: 469 year: 2001 ident: 2536_CR167 publication-title: Acta Psychiatr Scand doi: 10.1046/j.0001-690X.2001.acp1c008d.x contributor: fullname: GW MacEwan – volume: 101 start-page: 8467 year: 2004 ident: 2536_CR129 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0308455101 contributor: fullname: ME Jackson – volume: 31 start-page: 47 year: 1988 ident: 2536_CR84 publication-title: Behav Brain Res doi: 10.1016/0166-4328(88)90157-X contributor: fullname: A Ennaceur – volume: 62 start-page: 450 year: 2010 ident: 2536_CR44 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2010.05.004 contributor: fullname: J Camarasa – volume: 35 start-page: 2262 year: 2010 ident: 2536_CR202 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2010.100 contributor: fullname: CM O’Tuathaigh – volume: 190 start-page: 515 year: 2007 ident: 2536_CR17 publication-title: Br J Psychiatry doi: 10.1192/bjp.bp.106.024448 contributor: fullname: JH Barnett – volume: 24 start-page: 2894 year: 2006 ident: 2536_CR24 publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2006.05170.x contributor: fullname: M Bianchi – volume: 37 start-page: 416 year: 2011 ident: 2536_CR121 publication-title: Schizophr Bull doi: 10.1093/schbul/sbp089 contributor: fullname: LE Hong – volume: 15 start-page: 730 year: 2005 ident: 2536_CR38 publication-title: Curr Opin Neurobiol doi: 10.1016/j.conb.2005.10.014 contributor: fullname: TJ Bussey – volume: 36 start-page: 782 year: 2011 ident: 2536_CR222 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2010.212 contributor: fullname: CM Reichel – volume: 31 start-page: 637 year: 2006 ident: 2536_CR251 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300881 contributor: fullname: RC Smith – ident: 2536_CR21 – volume: 40 start-page: 385 year: 1985 ident: 2536_CR266 publication-title: Am Psychol doi: 10.1037/0003-066X.40.4.385 contributor: fullname: E Tulving – volume: 85 start-page: 253 year: 2006 ident: 2536_CR67 publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2006.08.007 contributor: fullname: N Bruin de – volume: 9 start-page: 67 year: 1993 ident: 2536_CR162 publication-title: Neuropsychopharmacology doi: 10.1038/npp.1993.44 contributor: fullname: BK Lipska – volume: 46 start-page: 1273 year: 2003 ident: 2536_CR224 publication-title: J Med Chem doi: 10.1021/jm021085c contributor: fullname: C Riemer – volume: 153 start-page: 273 year: 2004 ident: 2536_CR106 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2003.12.004 contributor: fullname: DK Hannesson – volume: 48 start-page: 651 year: 2000 ident: 2536_CR115 publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(00)00919-7 contributor: fullname: S Heckers – volume: 357 start-page: 1083 year: 2002 ident: 2536_CR33 publication-title: Philos Trans R Soc Lond B Biol Sci doi: 10.1098/rstb.2002.1097 contributor: fullname: MW Brown – volume: 329 start-page: 459 year: 2009 ident: 2536_CR230 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.150094 contributor: fullname: R Roncarati – volume: 208 start-page: 132 year: 2010 ident: 2536_CR178 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2009.11.018 contributor: fullname: CE McKibben – volume: 97 start-page: 107 year: 1998 ident: 2536_CR187 publication-title: Behav Brain Res doi: 10.1016/S0166-4328(98)00032-1 contributor: fullname: JB Mitchell – volume: 90 start-page: 374 year: 2008 ident: 2536_CR53 publication-title: Neurobiol Learn Mem doi: 10.1016/j.nlm.2008.04.009 contributor: fullname: JR Clarke – volume: 202 start-page: 111 year: 2009 ident: 2536_CR143 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1334-1 contributor: fullname: MV King – volume: 214 start-page: 254 year: 2010 ident: 2536_CR28 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2010.05.034 contributor: fullname: PH Botton – volume: 328 start-page: 921 year: 2009 ident: 2536_CR253 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.147884 contributor: fullname: SM Smith – ident: 2536_CR262 doi: 10.1111/j.1460-9568.2006.05259.x – volume: 20 start-page: 5434 year: 2010 ident: 2536_CR132 publication-title: Bioorg Med Chem Lett doi: 10.1016/j.bmcl.2010.07.097 contributor: fullname: DJ Johnson – volume: 14 start-page: 145 year: 2001 ident: 2536_CR174 publication-title: Eur J Neurosci doi: 10.1046/j.0953-816x.2001.01631.x contributor: fullname: PV Massey – volume: 110 start-page: 149 year: 2009 ident: 2536_CR252 publication-title: Schizophr Res doi: 10.1016/j.schres.2009.02.001 contributor: fullname: RC Smith – ident: 2536_CR218 doi: 10.1111/j.1601-183X.2010.00590.x – volume: 132 start-page: 303 year: 1997 ident: 2536_CR233 publication-title: Psychopharmacology (Berl) doi: 10.1007/s002130050349 contributor: fullname: F Sams-Dodd – volume: 338 start-page: R3 year: 1997 ident: 2536_CR229 publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(97)81951-6 contributor: fullname: H Rollema – volume: 32 start-page: 1 year: 2007 ident: 2536_CR25 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301189 contributor: fullname: B Biton – volume: 58 start-page: 365 year: 2010 ident: 2536_CR30 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2009.10.003 contributor: fullname: SR Bradley – volume: 113 start-page: 509 year: 1997 ident: 2536_CR86 publication-title: Exp Brain Res doi: 10.1007/PL00005603 contributor: fullname: A Ennaceur – volume: 18 start-page: 117 year: 2008 ident: 2536_CR144 publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2007.07.008 contributor: fullname: A Krivoy – volume: 78 start-page: 880 year: 2009 ident: 2536_CR260 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2009.07.005 contributor: fullname: S Sydserff – volume: 33 start-page: 2364 year: 2008 ident: 2536_CR77 publication-title: Neurochem Res doi: 10.1007/s11064-008-9796-4 contributor: fullname: Z Doleviczenyi – volume: 370 start-page: 319 year: 2007 ident: 2536_CR190 publication-title: Lancet doi: 10.1016/S0140-6736(07)61162-3 contributor: fullname: TH Moore – volume: 67 start-page: 1201 year: 2000 ident: 2536_CR257 publication-title: Am J Hum Genet doi: 10.1016/S0002-9297(07)62950-4 contributor: fullname: G Stober – volume: 20 start-page: 1178 year: 2010 ident: 2536_CR287 publication-title: Hippocampus doi: 10.1002/hipo.20864 contributor: fullname: AP Yonelinas – volume: 90 start-page: 285 year: 2010 ident: 2536_CR182 publication-title: Prog Neurobiol doi: 10.1016/j.pneurobio.2009.10.018 contributor: fullname: U Meyer – volume: 13 start-page: 1343 year: 2010 ident: 2536_CR199 publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145710000222 contributor: fullname: Y Noda – volume: 154 start-page: 1218 year: 2008 ident: 2536_CR6 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2008.05.011 contributor: fullname: B Aisa – volume: 31 start-page: 854 year: 2005 ident: 2536_CR228 publication-title: Schizophr Bull doi: 10.1093/schbul/sbi044 contributor: fullname: TW Robbins – volume: 318 start-page: 421 year: 1999 ident: 2536_CR125 publication-title: BMJ doi: 10.1136/bmj.318.7181.421 contributor: fullname: CM Hultman – volume: 16 start-page: 2034 year: 1996 ident: 2536_CR104 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.16-06-02034.1996 contributor: fullname: HC Grunze – volume: 11 start-page: 319 year: 2001 ident: 2536_CR168 publication-title: Bioorg Med Chem Lett doi: 10.1016/S0960-894X(00)00670-3 contributor: fullname: JE Macor – volume: 6 start-page: 348 year: 1994 ident: 2536_CR100 publication-title: J Neuropsychiatry Clin Neurosci doi: 10.1176/jnp.6.4.348 contributor: fullname: PS Goldman-Rakic – volume: 191 start-page: 745 year: 2007 ident: 2536_CR27 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-007-0698-y contributor: fullname: A Bortolozzi – volume: 30 start-page: 7236 year: 2010 ident: 2536_CR48 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0736-10.2010 contributor: fullname: CQ Chiu – volume: 148 start-page: 224 year: 1991 ident: 2536_CR76 publication-title: Am J Psychiatry doi: 10.1176/ajp.148.2.224 contributor: fullname: L Dixon – volume: 60 start-page: 1187 year: 2003 ident: 2536_CR259 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.60.12.1187 contributor: fullname: PF Sullivan – volume: 284 start-page: 1670 year: 1999 ident: 2536_CR57 publication-title: Science doi: 10.1126/science.284.5420.1670 contributor: fullname: JC Crabbe – volume: 1 start-page: 326 year: 1975 ident: 2536_CR186 publication-title: J Exp Psychol Anim Behav Process doi: 10.1037/0097-7403.1.4.326 contributor: fullname: M Mishkin – volume: 204 start-page: 251 year: 2009 ident: 2536_CR89 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1456-5 contributor: fullname: O Franberg – volume: 206 start-page: 403 year: 2009 ident: 2536_CR179 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-009-1618-0 contributor: fullname: SL McLean – volume: 281 start-page: 1349 year: 1998 ident: 2536_CR189 publication-title: Science doi: 10.1126/science.281.5381.1349 contributor: fullname: B Moghaddam – volume: 32 start-page: 1810 year: 2008 ident: 2536_CR7 publication-title: Prog Neuropsychopharmacol Biol Psychiatr doi: 10.1016/j.pnpbp.2008.08.001 contributor: fullname: S Akhondzadeh – volume: 10 start-page: 2307 year: 1999 ident: 2536_CR22 publication-title: Neuroreport doi: 10.1097/00001756-199908020-00016 contributor: fullname: HG Bernstein – volume: 214 start-page: 403 year: 2011 ident: 2536_CR61 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-010-2039-9 contributor: fullname: T Damgaard – volume: 61 start-page: 774 year: 2004 ident: 2536_CR35 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.61.8.774 contributor: fullname: AS Brown – ident: 2536_CR41 doi: 10.1016/j.neuropharm.2011.04.011 – volume: 130 start-page: 23 year: 2000 ident: 2536_CR65 publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0703288 contributor: fullname: LA Dawson – volume: 28 start-page: 1760 year: 2003 ident: 2536_CR236 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300225 contributor: fullname: M Schneider – volume: 115 start-page: 41 year: 2009 ident: 2536_CR105 publication-title: Schizophr Res doi: 10.1016/j.schres.2009.08.002 contributor: fullname: Y Guo – volume: 174 start-page: 334 year: 2004 ident: 2536_CR193 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-003-1764-8 contributor: fullname: CS Myers – volume: 211 start-page: 277 year: 2010 ident: 2536_CR165 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-010-1896-6 contributor: fullname: LE Long – volume: 214 start-page: 269 year: 2010 ident: 2536_CR134 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-010-1931-7 contributor: fullname: CA Jones – volume: 24 start-page: 5901 year: 2004 ident: 2536_CR278 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1346-04.2004 contributor: fullname: BD Winters – volume: 86 start-page: 1100 year: 1974 ident: 2536_CR97 publication-title: J Comp Physiol Psychol doi: 10.1037/h0037649 contributor: fullname: D Gaffan – volume: 120 start-page: 142 year: 1995 ident: 2536_CR133 publication-title: Psychopharmacology (Berl) doi: 10.1007/BF02246186 contributor: fullname: DN Jones – volume: 61 start-page: 515 year: 2007 ident: 2536_CR52 publication-title: Synapse doi: 10.1002/syn.20397 contributor: fullname: RE Clark – volume: 596 start-page: 89 year: 2008 ident: 2536_CR159 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2008.08.009 contributor: fullname: Z Li – volume: 93 start-page: 482 year: 2009 ident: 2536_CR118 publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2009.06.013 contributor: fullname: A Higuera-Matas – volume: 165 start-page: 1040 year: 2008 ident: 2536_CR93 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2008.07071135 contributor: fullname: R Freedman – volume: 28 start-page: 8709 year: 2008 ident: 2536_CR206 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2077-08.2008 contributor: fullname: F Papaleo – volume: 122 start-page: 150 year: 2009 ident: 2536_CR288 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2009.02.004 contributor: fullname: JW Young – volume: 67 start-page: 165 year: 1995 ident: 2536_CR256 publication-title: Behav Brain Res doi: 10.1016/0166-4328(94)00157-B contributor: fullname: T Steckler – volume: 34 start-page: 5 year: 2010 ident: 2536_CR29 publication-title: Prog Neuropsychopharmacol Biol Psychiatr doi: 10.1016/j.pnpbp.2009.09.001 contributor: fullname: A Boultadakis – volume: 24 start-page: 930 year: 2010 ident: 2536_CR128 publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2010.03.004 contributor: fullname: HT Ito – volume: 1279 start-page: 189 year: 2009 ident: 2536_CR147 publication-title: Brain Res doi: 10.1016/j.brainres.2009.05.004 contributor: fullname: S Kunitachi – volume: 12 start-page: 221 year: 2005 ident: 2536_CR81 publication-title: Learn Mem doi: 10.1101/lm.92505 contributor: fullname: MJ Eacott – volume: 20 start-page: 11 year: 1957 ident: 2536_CR241 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.20.1.11 contributor: fullname: WB Scoville – volume: 15 start-page: 429 year: 1996 ident: 2536_CR156 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(96)00018-8 contributor: fullname: ED Levin – volume: 336 start-page: 242 year: 2011 ident: 2536_CR272 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.110.171892 contributor: fullname: TL Wallace – volume: 59 start-page: 29 year: 2003 ident: 2536_CR36 publication-title: Schizophr Res doi: 10.1016/S0920-9964(01)00387-5 contributor: fullname: RW Buchanan – volume: 105 start-page: 655 year: 2001 ident: 2536_CR90 publication-title: Am J Med Genet doi: 10.1002/ajmg.1548 contributor: fullname: R Freedman – volume: 214 start-page: 843 year: 2010 ident: 2536_CR254 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-010-2091-5 contributor: fullname: S Snigdha – volume: 106 start-page: 20039 year: 2009 ident: 2536_CR263 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0908840106 contributor: fullname: V Tretter – volume: 15 start-page: 215 year: 2003 ident: 2536_CR135 publication-title: J Neuropsychiatry Clin Neurosci doi: 10.1176/appi.neuropsych.15.2.215 contributor: fullname: AD Kalechstein – volume: 327 start-page: 827 year: 2008 ident: 2536_CR164 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.136580 contributor: fullname: F Liu – volume: 365 start-page: 441 year: 1993 ident: 2536_CR243 publication-title: Nature doi: 10.1038/365441a0 contributor: fullname: P Seeman – volume: 276 start-page: 11487 year: 2001 ident: 2536_CR290 publication-title: J Biol Chem doi: 10.1074/jbc.M007631200 contributor: fullname: P Zanassi – volume: 170 start-page: 800 year: 2010 ident: 2536_CR79 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2010.07.042 contributor: fullname: L Duffy – volume: 10 start-page: 156 year: 2009 ident: 2536_CR49 publication-title: World J Biol Psychiatry doi: 10.1080/15622970701432551 contributor: fullname: YC Chung |
SSID | ssj0000484 ssj0068394 |
Score | 2.4114711 |
SecondaryResourceType | review_article |
Snippet | Rationale
Spontaneous (novel) object recognition (SOR) is one of the most widely used rodent behavioural tests. The opportunity for rapid data collection has... Spontaneous (novel) object recognition (SOR) is one of the most widely used rodent behavioural tests. The opportunity for rapid data collection has made SOR a... Rationale Spontaneous (novel) object recognition (SOR) is one of the most widely used rodent behavioral tests. The opportunity for rapid data collection has... Spontaneous (novel) object recognition (SOR) is one of the most widely used rodent behavioral tests. The opportunity for rapid data collection has made SOR a... Rationale: Spontaneous (novel) object recognition (SOR) is one of the most widely used rodent behavioural tests. The opportunity for rapid data collection has... |
SourceID | proquest gale crossref pubmed pascalfrancis springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 647 |
SubjectTerms | Acetylcholine receptors Acetylcholine receptors (muscarinic) Adult and adolescent clinical studies Animal behavior Animal cognition Animal memory Animal models Animals Antipsychotic Agents - therapeutic use Biological and medical sciences Biomedical and Life Sciences Biomedicine Cannabinoids Cognition Disorders - drug therapy Cognition Disorders - genetics Cognition Disorders - pathology Cognitive ability Communications equipment Data collections Disease Models, Animal Dopamine Drugs GABA gamma -Aminobutyric acid Genetically modified organisms Glutamate Glutamic acid Humans Immune response Medical sciences Memory Mental disorders Mice neuregulin Neurosciences Pattern recognition Pharmacology/Toxicology Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Psychoses Rats Recognition (Psychology) - drug effects Recognition (Psychology) - physiology Review Reviews Rodentia Rodents Schizophrenia Schizophrenia - drug therapy Schizophrenia - genetics Schizophrenia - pathology Serotonin S6 receptors Species Specificity Time Factors Translation |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ti9QwEA56gggier7VO48R5ATd4iZt2sYvcojHISgH3sF-K0maHIK09dr7cD_G_-pM-ubiy7fuNpu0O08mT5tnZhh7qXJLiapE7EQu4zTV6AeV1bHnmam4R4JRBYHsl-zkPP20kZtRm9ONssrJJwZHXTWW3pG_VQguZPeZfN_-iKloFG2ujhU0brJbXOBKjnDON_niiFOKwRw-ZEgEhozMCcWTyWLa4VyHhKKCahxwHguZZLHcWqNGT3231R3-a34od_E3PvrHXmpYoo7vs3sjt4SjAQwP2A1X77Lbn8fd8112eDrkqb5ewdkSdtWt4BBOlwzW1w_Zz69tUyNrdM1VB42hVzUwK42aGnRdwbe-Ayq4EiQE0DfQ_S7fewcahqgYaDyEjfH6ogMKZoF2GYsQsgLEMIVSruC766buq0XMhLeEXh4PIJTt6R6x8-OPZx9O4rGOQ2ylUn3MjTK54t6qvCItnCkMN-gsnLFGF17gdxqJvnXKJd5ZLrwurLGZx0ZSI395zHbqpnZPGSRemXXuK8OFTaXLDB6vVbXWSZ7gT_KIvZ4sV7ZDuo5yTswczFyimUsycykj9opsW9JU7i-11WNEAg5FSbHKowTpZY7PY9hyf6slTkG7dfpgCx3z0FQiMMFH8IjtTXApRx_RlTOiI_ZiPks9k-wtWJiuuyhSiSQxYk8GlC19CwR1KlXE3kywW_r-5z0_---V7LE7giZuUCbts53-8so9R9LVm4MwtX4BdTEpfw priority: 102 providerName: ProQuest |
Title | Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models |
URI | https://link.springer.com/article/10.1007/s00213-011-2536-5 https://www.ncbi.nlm.nih.gov/pubmed/22068459 https://www.proquest.com/docview/942528765 https://search.proquest.com/docview/1008845584 |
Volume | 220 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3rb9MwELf2kBAS4jEYKxvVIaEhQVM1Dycx3wrqmEBMFaxS-RTZjo3QpqRa0g_jf-F_5S5Pqo0P-5SXc67r890597s7xl6LSFOiKs8xXsSdIJAoB4WWjnVDlboWDYy0AsiehaeL4POSL7eY1326yC7GrUeyEtRdrBtpI4L-uI7H_dDh22wXVQ8txt3ppx9fZr38DSj0sr4IUf_XiZh9CiPjcevYvI3ihmpqBPSDlSzwz7J1lYvbzNAbLtRKM508qqMFiyqhIQFSLsbrUo3175vpHu8w6MfsYWOowrTmrCdsy2R77N7XxhW_x47nddLr6xGc9zFcxQiOYd6nw75-yv58X-UZmqAmXxeQK_ruAx1sKc9AZin8Kgug6i0VHgHKHIp_sYDvQUIdYgO5hcrLnv0sgCJjYNX3Rew2AlwQFJc5gktTtOTTHhmFQ0KVgSdQ1QAqnrHFyez846nTFIVwNBeidFwlVCRcq0WUErBOxcpVKHmM0krG1sN7EncN2gjjW6Ndz8pYKx1abMQlGkP7bCfLM3PAwLdCTSKbKtfTATehwvOJSCfSj3x8JRqwty0_JKs690fSZXmuZibBmUloZhI-YG-IYxKSC-WV1LIJb8CuKMNWMvXRVo1wc4ctjzZa4nrWG4-HGzzXdU31Bn3czw_YYcuESSNwikSg7MXNb4ivv-qeEmXC0FUzTL87jgOOFueAPa95t6ft4VIJuBiwdy0j9rT_O-YXd2p9yO57JBUq2NMR2ymv1uYlWnSlGrLtaBkNm4WMxw-zs_k3vLvwpn8B4glFdQ |
link.rule.ids | 314,780,784,12056,21388,27924,27925,31719,31720,33744,33745,41081,41523,42150,42592,43310,43805,52111,52234,73745,74302 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3bbtQwEB3BVgIkhKDcQksxEioS3YjNxUnMCyqo1QLtagVbqW-R7dgICSWhSR_6MfwrM4mzYcXlLZs4drJzPDmJz8wAvBCppkRVoW_ClPtxLNEPCi19GySqCCwSjKITyC6S-Vn88ZyfO21O42SVg0_sHHVRafpG_loguJDdJ_xt_cOnolG0uOoqaFyHLUqcziew9e5osfw8uuKYojD7HwlSgT4nc0QRZTwb1jhnXUrRkKocBIEf8ijx-cZTyvnq27Vs8H-zfcGLvzHSP1ZTu4fU8V2449glO-zhcA-umXIbbpy69fNt2F_2maqvpmw1Bl41U7bPlmMO66v78PNLXZXIG0112bBK0ccattYaVSWTZcG-tQ2jkiudiIC1FWt-F_C9YZL1cTGssqxbGi-_NozCWVg9jkUYmTJEMQVTTtl30wzdF6OcCW8J_TxusK5wT_MAzo6PVu_nvqvk4GsuROsHSqhUBFaLtCA1nMpUoNBdGKWVzGyI-yRSfW2EiazRQWhlppVOLDbiEhnMQ5iUVWkeA4usULPUFioIdcxNonB7JoqZjNIIT0k9eDVYLq_7hB35OjVzZ-YczZyTmXPuwUuybU6Tub2QWrqYBByK0mLlhxESzBTfyLDl7kZLnIR64_DeBjrWQ1ORwAhfwj3YGeCSOy_R5GtMe_B8fZR6JuFbZ2G67iyLOdJEDx71KBv7DhHUMRceHAywG_v-5z0_-e-VPIOb89XpSX7yYfFpB26FNI07ndIuTNqLS_MUKVir9txE-wWkZy3V |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9RAFB50C0UQ0ao1ttYjSAXd0NwmyfgiVbvU27JoC30LM5MZEUqybdKH_hj_q-ckk42Ll7fsZnYm2XOZLznfOYex5yLTVKgq8k2UcT9JJPpBoaVvw1SVoUWAUXYE2Xl6fJp8PONnrqRQ42iVg0_sHHVZa3pHfiBQuRDdp_zAOlbE4v3szfLCpwZSFGh13TRusg3cFINowjbeHs0XX0e3nFBGZv8hRVjQ12eOKbuM50O8M-jKi0bU8SAM_YjHqc_Xdiznt28vZYP_oe2bX_wNnf4RWe02rNlddschTTjsVeMeu2GqLbb5xcXSt9j-oq9afT2FkzEJq5nCPizGetbX99nPb8u6Qgxp6qsGakUvbmDFO6orkFUJP9oGqP1KRyiAtobmdzLfa5DQ58hAbaELk1ffG6DUFliOa5G-TAE1mhIrp3BummH6cqQ24S2hz8cD6Jr4NA_Y6ezo5N2x77o6-JoL0fqhEioTodUiK4kZp3IVKnQdRmklcxvhdxJhvzbCxNboMLIy10qnFgdxiWjmIZtUdWUeMYitUEFmSxVGOuEmVXgciDKQcRbjTzKPvRwkVyz74h3FqkxzJ-YCxVyQmAvusRck24IMu72UWrr8BFyKSmQVhzGCzQyfznDk7tpINEi9dnpvTTtWS1PDwBgfyD22M6hL4TxGU6z022PPVmdpZiLBdRKm687zhCNk9Nh2r2Xj3BEqdcKFx14NajfO_c97fvzfK3nKNtHGis8f5p922K2ILLqjLO2ySXt5ZZ4gGmvVnrOzX-ZJMgI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Spontaneous+object+recognition+and+its+relevance+to+schizophrenia%3A+a+review+of+findings+from+pharmacological%2C+genetic%2C+lesion+and+developmental+rodent+models&rft.jtitle=Psychopharmacologia&rft.au=LYON%2C+L&rft.au=SAKSIDA%2C+L.+M&rft.au=BUSSEY%2C+T.+J&rft.date=2012-04-01&rft.pub=Springer&rft.issn=0033-3158&rft.eissn=1432-2072&rft.volume=220&rft.issue=4&rft.spage=647&rft.epage=672&rft_id=info:doi/10.1007%2Fs00213-011-2536-5&rft.externalDBID=n%2Fa&rft.externalDocID=25703254 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon |